The mission of the Oncology DONET is to become a connecting platform for patient-oriented clinical research in the field of solid tumours \u2013 a place where science genuinely benefits patients through the use of real-world data, innovative study design, and the sharing of expert capacities.<\/p>\n
[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ custom_padding=”|||” custom_padding_tablet=”|||||true” custom_padding_last_edited=”off|desktop” global_colors_info=”{}” padding_tablet=”|||||true” padding_last_edited=”off|desktop” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.27.4″ text_font=”||||||||” header_font=”||||||||” header_3_font=”Faustina|600|||||||” header_3_text_color=”#0e7162″ header_3_font_size=”26px” header_3_line_height=”1.2em” max_width=”600px” animation_style=”fade” header_3_font_size_tablet=”22px” header_3_font_size_phone=”18px” header_3_font_size_last_edited=”on|tablet” locked=”off” global_colors_info=”{}” header_2_font_size__hover=”26px” header_2_font_size__hover_enabled=”26px” header_2_letter_spacing__hover=”0px” header_2_letter_spacing__hover_enabled=”0px” header_2_line_height__hover=”1em” header_2_line_height__hover_enabled=”1em” header_2_text_shadow_style__hover=”none” header_2_text_shadow_style__hover_enabled=”none” header_2_text_shadow_color__hover=”rgba(0,0,0,0.4)” header_2_text_shadow_color__hover_enabled=”rgba(0,0,0,0.4)”]<\/p>\n
Vision CZECRIN | ONCO<\/span><\/h3>\n\n- Establishment and support of a network of<\/strong> clinical and academic centres collaborating<\/strong> in the field of solid tumour research<\/li>\n
- Supporting independent clinical trials<\/strong> reflecting the needs of clinical practice and patients<\/li>\n
- Providing expert and methodological support<\/strong> in the field of clinical trial design, regulation, data management, monitoring, pharmacovigilance, etc.<\/li>\n
- Use of real-world data<\/strong> (RWD) and creation of real-world evidence (RWE)<\/li>\n
- Strengthening international cooperation<\/strong><\/li>\n<\/ul>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ fullwidth=”on” admin_label=”Co je CZECRIN ONCO” _builder_version=”4.27.4″ collapsed=”off” global_colors_info=”{}” box_shadow_style__hover=”none” box_shadow_style__hover_enabled=”none” box_shadow_color__hover=”rgba(0,0,0,0.3)” box_shadow_color__hover_enabled=”rgba(0,0,0,0.3)”][et_pb_fullwidth_header title=”CZECRIN | ONCO is an industry-oriented network” text_orientation=”center” header_fullscreen=”on” button_two_text=”We want to be part of CZECRIN | ONCO” button_two_url=”” background_overlay_color=”rgba(113,216,255,0.22)” _builder_version=”4.27.4″ title_font=”Faustina|600|||||||” title_font_size=”40px” title_line_height=”1.4em” content_font=”||||||||” background_enable_color=”off” background_image=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/10\/CZECRIN-onco.jpg” background_position=”center_left” custom_button_one=”on” button_one_text_size=”14px” button_one_text_color=”#ffffff” button_one_bg_color=”#26c699″ button_one_border_width=”8px” button_one_border_color=”rgba(0,0,0,0)” button_one_letter_spacing=”1px” button_one_font=”|700||on|||||” custom_button_two=”on” button_two_text_size=”16px” button_two_text_color=”#FFFFFF” button_two_bg_color=”rgba(29,52,96,0.6)” button_two_border_width=”0px” button_two_border_color=”#263077″ button_two_letter_spacing=”1px” button_two_font=”|700||on|||||” button_two_icon=”||divi||400″ button_two_icon_color=”#F2F8FF” button_two_icon_placement=”left” custom_margin=”|||||false” custom_padding=”10vw||10vw||true” link_option_url_new_window=”on” title_font_size_tablet=”32px” title_font_size_phone=”22px” title_font_size_last_edited=”on|desktop” button_two_text_shadow_style=”preset1″ box_shadow_style_button_two=”preset1″ global_colors_info=”{}”]<\/p>\n
which aims to support the design, implementation and development of academic clinical trials in this area – from protocol design to the implementation of results into clinical practice. It was established in 2020 to systematically support academic clinical research in the field of solid tumours. It responds to the specific patient needs and challenges of this rapidly evolving field. <\/p>\n
<\/p>\n
The CZECRIN | ONCO network connects cancer centres, research teams and clinical experts who want to actively participate in academic and sponsored clinical trials in the field of oncology. If you are interested in collaborating or joining the network, please fill out the following form. <\/p>\n
<\/p>\n
[\/et_pb_fullwidth_header][et_pb_fullwidth_image _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_fullwidth_image][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|phone” admin_label=”Mapa” _builder_version=”4.27.4″ background_color=”#f2f2fa” use_background_color_gradient=”on” background_color_gradient_stops=”#ffffff 0%|#f2f2fa 50%” background_color_gradient_start=”#ffffff” background_color_gradient_end=”#f2f2fa” background_color_gradient_end_position=”50%” background_size=”initial” z_index=”99″ overflow-x=”visible” overflow-y=”visible” custom_margin=”|||” custom_margin_tablet=”” custom_margin_phone=”” custom_margin_last_edited=”on|phone” custom_padding=”|||” custom_padding_tablet=”|||” custom_padding_phone=”|||” bottom_divider_style=”ramp” bottom_divider_color=”#ffffff” bottom_divider_height=”200px” bottom_divider_flip=”horizontal” saved_tabs=”all” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_heading title=”Connected centres in the CZECRIN DONET network | ONCO” _builder_version=”4.27.4″ _module_preset=”default” title_level=”h2″ global_colors_info=”{}”][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.4″ locked=”off” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.27.4″ text_font=”||||||||” text_font_size=”16px” ul_font=”||||||||” header_font=”||||||||” header_2_font=”Roboto|700|||||||” header_2_font_size=”45px” header_2_line_height=”1.2em” header_3_font=”||||||||” text_orientation=”center” max_width_last_edited=”off|desktop” module_alignment=”center” custom_margin=”|||” custom_padding=”|||” header_2_font_size_tablet=”35px” header_2_font_size_phone=”28px” header_2_font_size_last_edited=”on|phone” global_colors_info=”{}”]<\/p>\n
The DONET network CZECRIN | ONCO<\/strong> includes sites across the Czech Republic that share know-how, coordinate research activities and contribute to strengthening the quality of independent studies in the field. All centres collaborate on the GENESIS<\/a><\/strong> project .<\/strong> <\/p>\n<\/strong><\/p>\n[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.27.4″ _module_preset=”default” custom_padding=”20px|20px|20px|20px|false|false” border_radii=”on|10px|10px|10px|10px” box_shadow_style=”preset1″ box_shadow_blur=”12px” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_map address=”Palachovo n\u00e1m. 726\/2, 625 00 Brno-Star\u00fd L\u00edskovec, \u010cesko” zoom_level=”6″ address_lat=”49.758883197778″ address_lng=”15.432271904983″ _builder_version=”4.27.4″ _module_preset=”default” background_enable_color=”off” animation_style=”slide” link_option_url_new_window=”on” hover_enabled=”0″ box_shadow_style=”preset1″ global_colors_info=”{}” sticky_enabled=”0″][et_pb_map_pin title=”Fakultn\u00ed nemocnice u\u00a0sv.\u00a0Anny v\u00a0Brn\u011b” pin_address=”Peka\u0159sk\u00e1 664\/53, 656 91 Brno-st\u0159ed, \u010cesko” pin_address_lat=”49.191327″ pin_address_lng=”16.5993373″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
Centre for Clinical Studies St. Anne’s Hospital in Brno <\/strong> is an important partner for CZECRIN, providing complete support for clinical trials in the hospital. It coordinates all processes, communicates with sponsors of commercial studies and participates in the implementation of academic projects. At the same time, it acts as a point of contact for patients and volunteers. The centre assists with the preparation of documentation for regulatory authorities, contracting with partner centres and monitoring studies, thus ensuring the quality and safe conduct of clinical trials. <\/p>\nSt. Anne’s University Hospital in Brno – homepage | FNUSA <\/a><\/strong><\/p>\nCentre for Clinical Studies | FNUSA<\/a><\/strong><\/p>\nMUDr. Jana Katolick\u00e1, Ph.D.<\/strong>
Head of the Oncology and Surgery Department
St. Anne’s University Hospital in Brno <\/p>\n![\"The](\"https:\/\/www.fnusa.cz\/wp-content\/uploads\/2024\/09\/fnusa-logo-webu.png\")
<\/p>\n
[\/et_pb_map_pin][et_pb_map_pin title=”Masaryk Institute of Oncology” pin_address=”656 53, \u017dlut\u00fd kopec 543\/7, 602 00 Brno-st\u0159ed-Star\u00e9 Brno, \u010cesko” pin_address_lat=”49.1948263″ pin_address_lng=”16.5891581″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
The Masaryk Institute of Oncology (MO\u00da)<\/b> is a key partner of the CZECRIN network. It is home to the first Centre for Precision Oncology in the Czech Republic, which in cooperation with CZECRIN established the GENESIS<\/b> project. This national platform aims to unify procedures, share data and analyse the effectiveness of modern targeted therapies across the Czech Republic. The Centre is also actively involved in recruiting patients for clinical trials. <\/p>\n
You can read more about precision oncology here.<\/a><\/p>\n![\"MOU](\"https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/02\/MOU_pruhledne-300x182.png\")
<\/p>\n
[\/et_pb_map_pin][et_pb_map_pin title=”University Hospital Brno” pin_address=”Jihlavsk\u00e1 340\/20, 625 00 Brno-Star\u00fd L\u00edskovec, \u010cesko” pin_address_lat=”49.1753832″ pin_address_lng=”16.5695055″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
The Clinical Trials Department of the Brno University Hospital<\/strong>, which falls under the Office of the Deputy Minister for Science and Research, provides administrative support for clinical trials across the hospital’s clinics. The team prepares contracts and budgets with sponsors, controls payments, keeps records of studies and prepares documents for invoicing and cost accounting. Support includes the involvement of OKS study coordinators in specific projects and coordination of the contract negotiation process in collaboration with the Legal Affairs Department. The Unit also manages the CTIS identifiers of the various departments and provides contact support for the contracting authorities and partner centres. <\/p>\nDepartment of Clinical Studies – University Hospital Brno<\/a><\/p>\nMUDr. Michal Eid<\/strong>
Doctor of the Internal Hematology and Oncology Clinic
University Hospital Brno<\/p>\n![\"Downloads](\"https:\/\/www.fnbrno.cz\/fn-brno-logo\/f6651\")
<\/p>\n
[\/et_pb_map_pin][et_pb_map_pin title=”University Hospital Ostrava” pin_address=”5 708, 17. listopadu 1790\/5, 708 00 Ostrava-Poruba, \u010cesko” pin_address_lat=”49.8278637″ pin_address_lng=”18.1620609″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
The Clinical Trials Centre of the Ostrava University Hospital<\/strong> is a key place for initiating and coordinating clinical trials in the hospital. It serves as a link between study sponsors and investigators, ensuring fast, accurate and efficient communication. It enters the process as an administrative, financial and control authority and no clinical trial can be implemented at FNO without its approval. Its main objective is to simplify and speed up all processes related to the conduct of studies. Since 2016, FN Ostrava has been part of the national research infrastructure CZECRIN, which supports academic clinical trials and operates in connection with the European ECRIN network. <\/p>\nCentre for Clinical Studies (CKS) | University Hospital Ostrava<\/a><\/p>\ndoc. MUDr. Ing. Jakub Cvek, Ph.D.<\/strong>
Head of the Oncology Clinic
University Hospital Ostrava<\/p>\n![\"FNO](\"https:\/\/www.fno.cz\/public\/fno\/img\/logo.svg\")
<\/p>\n
[\/et_pb_map_pin][et_pb_map_pin title=”University Hospital Hradec Kr\u00e1lov\u00e9” pin_address=”Sokolsk\u00e1 581, 500 05 Hradec Kr\u00e1lov\u00e9-Nov\u00fd Hradec Kr\u00e1lov\u00e9, \u010cesko” pin_address_lat=”50.1979291″ pin_address_lng=”15.8263686″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
The Hradec Kr\u00e1lov\u00e9<\/strong> University Hospital<\/strong> offers its partners comprehensive cooperation in the field of clinical evaluation of drugs and medical devices, which it provides at the level of a top medical facility with modern equipment and experienced experts. In recent years, the interest in the implementation of studies has been growing significantly, especially in the fields of oncology, hematology and neurology, but the hospital has long been a reliable partner in internal medicine and surgery. Clinical trials are conducted in accordance with Czech legislation, international standards and ethical principles. In order to start a study, it is necessary to submit complete documentation: from the application and protocol through the approval of the S\u00daKL and the ethics committee to the draft contract with economic calculation and related manuals and forms. <\/p>\nClinical evaluation of medicines | University Hospital Hradec Kr\u00e1lov\u00e9<\/a><\/p>\ndoc. MUDr. Milan Vo\u0161mik, Ph.D.<\/strong>
Head of the Department of Oncology and Radiotherapy
Hradec Kr\u00e1lov\u00e9 University Hospital<\/p>\n![\"Logo](\"https:\/\/encrypted-tbn0.gstatic.com\/images?q=tbn:ANd9GcQQUOFLHHsv3Eogr9HJgf9fnWYnGoyV46ZLAA&s\")
<\/p>\n
[\/et_pb_map_pin][et_pb_map_pin title=”Thomayer University Hospital” pin_address=”140 59, V\u00edde\u0148sk\u00e1 800, 140 00 Praha 4-Kr\u010d, \u010cesko” pin_address_lat=”50.0294283″ pin_address_lng=”14.4574157″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
Thomayer University Hospital<\/strong> is an active member of the national and European infrastructure CZECRIN, which supports academic clinical research and connects Czech institutions with international projects through the ECRIN-ERIC network. CZECRIN brings together key clinical centres, offers expert capacities for research and development of drugs and medical devices and sets quality standards for processes and data in accordance with FAIR principles. At the same time, it is dedicated to education and competence development in the field of clinical trials, thus strengthening the professional background for the implementation of academic trials throughout the Czech Republic. <\/p>\nClinical research | Fakultn\u00ed Thomayerova nemocnice<\/a><\/p>\ndoc. MUDr. Radka Lohynsk\u00e1, Ph.D.<\/strong>
Head of the Oncology Clinic
Thomayer University Hospital<\/p>\n![\"Thomayer](\"https:\/\/www.ftn.cz\/files\/clanky\/1128.jpg\")
<\/p>\n
[\/et_pb_map_pin][et_pb_map_pin title=”Motol University Hospital” pin_address=”V \u00davalu 84, 150 06 Praha 5, \u010cesko” pin_address_lat=”50.0734726″ pin_address_lng=”14.3406404″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
The Clinical Trials Department of Motol Hospital<\/strong> provides administrative support for commercial and academic studies conducted at the hospital and works closely with CZECRIN. The Motol Hospital is the venue for clinical trials of drugs and medical devices and academic clinical trials, where the team provides support from submission to the S\u00daKL and ethics committees, through the preparation of synopses and informed consents to the conclusion of contracts with partner centres and monitoring of studies. <\/p>\nClinical evaluation at Motol University Hospital – Motol University Hospital<\/a><\/p>\n![](\"https:\/\/www.fnmotol.cz\/wp-content\/uploads\/2024\/05\/logo.svg\")
<\/p>\n
prof. MUDr. Tom\u00e1\u0161 B\u00fcchler, Ph.D. <\/strong>
Head of the Oncology Clinic
University Hospital in Motol<\/p>\ndoc. MUDr. Kate\u0159ina Kope\u010dkov\u00e1, Ph.D.<\/strong>
Doctor, Oncology Clinic
Motol University Hospital<\/p>\n[\/et_pb_map_pin][et_pb_map_pin title=”General University Hospital” pin_address=”U Nemocnice 499\/2, 128 08 Praha 2-Nov\u00e9 M\u011bsto, \u010cesko” pin_address_lat=”50.0733909″ pin_address_lng=”14.421015″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
The Clinical Trials and Research Department of the VFN<\/strong> provides comprehensive administrative and professional support in the initiation and implementation of clinical trials. It provides communication with sponsors and CROs, coordinates the start-up phase including legal and economic review of contracts, and links clinics with sites such as laboratories, pharmacy and imaging. It also supports investigator-initiated academic projects (IITs), assists staff with preparation of documents, study billing, payment control and record keeping. The department participates in inspections and audits, coordinates the archiving of documentation, and ensures the payment of travel reimbursements to patients. <\/p>\nClinical Evaluation and Research – General University Hospital in Prague<\/a><\/p>\ndoc. MUDr. Michal Vo\u010dka, Ph.D.<\/strong>
Head of the Oncology Clinic
General University Hospital in Prague<\/p>\n![\"General](\"https:\/\/www.vfn.cz\/wp-content\/themes\/tm-beans-child\/img\/vfn-logo-web-kruh-cj.svg\")
<\/p>\n
[\/et_pb_map_pin][et_pb_map_pin title=”University Hospital Pilsen” pin_address=”E. Bene\u0161e 1128\/13, 301 00 Plze\u0148 3, \u010cesko” pin_address_lat=”49.7319938″ pin_address_lng=”13.3755267″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
The University Hospital Plze\u0148<\/strong> has long been involved in the implementation of clinical trials across a wide spectrum of medical disciplines. As a modern teaching facility with highly specialised facilities, it is involved in both commercial and academic projects and provides the expertise of doctors, study coordinators and specialised departments. Clinical trials are conducted in accordance with current legislation and international standards, with an emphasis on patient safety and the quality of the data obtained. FN Plze\u0148 is dedicated to the development of new drugs and medical devices, as well as to supporting research activities within the national infrastructure CZECRIN and involves hundreds of patients in studies that contribute to the development of modern medicine. <\/p>\nUniversity Hospital Pilsen<\/a><\/p>\n![\"Faculty](\"https:\/\/encrypted-tbn0.gstatic.com\/images?q=tbn:ANd9GcQN7Eo5bQyU3PyEnxpd4Kz_QtTi3Mvjmsn5kw&s\")
<\/p>\n
[\/et_pb_map_pin][et_pb_map_pin title=”University Hospital Olomouc” pin_address=”Zdravotn\u00edk\u016f 248\/7, 779 00 Olomouc-Olomouc 9, \u010cesko” pin_address_lat=”49.5859341″ pin_address_lng=”17.2398797″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
Olomouc University Hospital<\/strong> is actively involved in conducting clinical trials of drugs and medical devices across specialist departments. As a modern university centre, it offers the facilities of top clinics, experienced teams of investigators and high-quality technical equipment. Studies are conducted in accordance with national legislation, international standards and ethical principles with an emphasis on patient safety and accuracy of the data obtained. The hospital cooperates with sponsors in the preparation of documentation and contracts and provides expert support throughout the duration of the clinical trial. <\/p>\nClinical evaluation of medicines and medical devices | University Hospital Olomouc<\/a><\/p>\nprof. MUDr. Bohuslav Melichar, Ph.D. <\/strong>
Head of the Oncology Clinic
University Hospital Olomouc<\/p>\n![\"Doctors](\"https:\/\/encrypted-tbn0.gstatic.com\/images?q=tbn:ANd9GcSBh9Xsw7vwUR9Vo670uo5o_Y56GMfKvtBfqg&s\")
<\/p>\n
[\/et_pb_map_pin][et_pb_map_pin title=”Kr\u00e1lovsk\u00e9 Vinohrady University Hospital” pin_address=”\u0160rob\u00e1rova 1150\/50, 100 00 Praha 10-Vinohrady, \u010cesko” pin_address_lat=”50.0742053″ pin_address_lng=”14.4764531″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
The Department of the Deputy Director for Science and Research at the Kr\u00e1lovsk\u00e9 Vinohrady Hospital<\/strong> provides comprehensive management of the scientific and research agenda across the hospital. It coordinates the development of science in clinical and laboratory departments, methodically leads research activities and supports the introduction of the most modern treatment procedures. At the same time, it is involved in the preparation and coordination of grant projects at national and international level, ensures the implementation and cooperation in clinical trials and oversees the effective use of funds resulting from the status of a research organisation. The department also includes an Ethics Committee and an Office for International Cooperation in Science and Research. <\/p>\nKr\u00e1lovsk\u00e9 Vinohrady University Hospital<\/a><\/p>\nprof. MUDr. Renata Soumarov\u00e1, Ph.D., MBA <\/strong>
Head of the Oncology Clinic
Kr\u00e1lovsk\u00e9 Vinohrady University Hospital<\/p>\n![\"Kr\u00e1lovsk\u00e9](\"https:\/\/www.fnkv.cz\/img\/logo2.gif\")
<\/strong><\/p>\n[\/et_pb_map_pin][\/et_pb_map][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
List of workplaces by region<\/strong><\/h5>\n[\/et_pb_text][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
Capital City of Prague<\/strong>
FN v Motole<\/a>, <\/span>Fakultn\u00ed Thomayerova nemocnice<\/a>, <\/span>V\u0161eobecn\u00e1 fakultn\u00ed nemocnice v Praze<\/a>, <\/span>FN Kr\u00e1lovsk\u00e9 Vinohrady<\/a><\/p>\nPilsen Region
<\/strong>FN Pilsen<\/a><\/p>\nHradec Kralove Region
<\/strong>FN Hradec Kr\u00e1lov\u00e9<\/a><\/p>\n[\/et_pb_text][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
South Moravian Region
<\/strong>FN u sv. Anny v Brn\u011b<\/a>, <\/span>FN Brno<\/a>, <\/span>Masaryk\u016fv onkologick\u00fd \u00fastav<\/a><\/p>\nOlomouc Region
<\/strong>FN Olomouc<\/a><\/p>\nMoravian-Silesian Region
<\/strong>FN Ostrava<\/a><\/p>\n[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Organiza\u010dn\u00ed struktura” _builder_version=”4.27.4″ _module_preset=”default” top_divider_color=”#FFFFFF” bottom_divider_color=”#F2F8FF” bottom_divider_flip=”horizontal” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_heading title=”Organisational structure” _builder_version=”4.27.4″ _module_preset=”default” title_level=”h2″ global_colors_info=”{}”][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” min_height=”174px” global_colors_info=”{}”]<\/p>\n
CZECRIN | ONCO<\/strong>, as a national network dedicated to supporting clinical research in the field of solid tumour oncology, has a governance structure that ensures transparent and efficient operation. The network operates under the auspices of the national research infrastructure CZECRIN<\/strong>. <\/p>\nAll participating institutions and partners have the opportunity to actively participate in shaping the research direction of the CZECRIN | ONCO<\/strong> network and thus contribute to the development of modern cancer care and increasing its availability and quality for patients in the Czech Republic.<\/p>\n[\/et_pb_text][et_pb_heading title=”Leading Investigator” _builder_version=”4.27.4″ _module_preset=”default” title_level=”h3″ global_colors_info=”{}”][\/et_pb_heading][et_pb_team_member name=”doc. MUDr. Radka Lordick Obermannov\u00e1, Ph.D.” position=”Leading Investigator” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/08\/Obermannova.jpg” icon_color=”#f88590″ _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_text_color=”#000000″ header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” text_orientation=”center” custom_margin=”||0px|” custom_padding=”30px|30px|30px|30px|true|true” animation_style=”zoom” animation_intensity_zoom=”8%” border_radii=”on|15px|15px|15px|15px” border_radii_image=”on|40px|40px|40px|40px” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” box_shadow_style_image=”preset1″ icon_hover_color=”#f73145″ global_colors_info=”{}” icon_color__hover=”#f73145″ icon_color__hover_enabled=”on”]<\/p>\n
Doc. MUDr. Radka Lordick Obermannov\u00e1, Ph.D. works as a consultant in the field of clinical oncology at the Department of Complex Oncological Care at the Masaryk Cancer Institute in Brno. She specializes in the treatment of patients with tumors of the gastrointestinal tract. She graduated from the Faculty of Medicine of Masaryk University in Brno, where she completed her specialisation training in clinical oncology and postgraduate doctoral studies. Her scientific focus on gastrointestinal cancers has shaped her research career, particularly her interest in optimizing multimodal treatment of esophageal cancer and identifying predictors of treatment response. <\/p>\n
Since 2012, she has been the lead physician of the Phase I Unit and is actively involved in the development of new drugs as a principal investigator and co-investigator of Phase I-III clinical trials. Since 2025 she has been the Head of the Clinical Trials Unit at Masaryk Cancer Institute. <\/p>\n
Doc. Lordick Obermann is the author of the national recommendations for the treatment of oesophageal and gastric cancer and co-author of the European ESMO recommendations for the treatment of oesophageal cancer. She is an active member of the ESMO Faculty Group on Non-Colorectal Gastrointestinal Cancer and participates in the leadership of the EORTC Gastric Cancer Working Group. She is also a member of the International Gastric Cancer Association (IGCA) and the Czech Cancer Society. <\/p>\n
[\/et_pb_team_member][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” custom_padding=”68px|||||” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_heading title=”Discipline Advisory Board” _builder_version=”4.27.4″ _module_preset=”default” title_level=”h3″ global_colors_info=”{}”][\/et_pb_heading][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
The specialty council is a professional platform of the specialty network, which aims to define research priorities in oncology. It focuses on promoting high quality research projects – from identifying topics with high clinical and scientific merit to reviewing proposals for national and international studies.<\/p>\n
Members of the specialty board are experienced representatives of the academic and clinical spheres. The implementation of relevant outputs of clinical trials into practice, e.g. by redefining recommended practices, is ensured by close links with the professional society, whose representatives are often also members of the Board.<\/p>\n
The Discipline Advisory Board\u00a0thus creates an autonomous professional framework for the strategic direction and development of research activities within the branch network.<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ use_custom_gutter=”on” module_class=”equal-boxes” _builder_version=”4.27.4″ max_width=”1440px” custom_padding=”|||” custom_css_free_form=”.equal-boxes {|| display: flex;||}||||.equal-boxes > .et_pb_column {|| display: flex;||}||||.equal-boxes .et_pb_module {|| height: 100%;||}||” use_custom_width=”on” custom_width_px=”1440px” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”prof. MUDr. Tom\u00e1\u0161 B\u00fcchler, Ph.D. ” position=”Head of the Oncology Clinic” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/11\/Buchler-2.jpg” icon_color=”#f88590″ _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” text_orientation=”center” custom_margin=”||0px|” custom_padding=”30px|30px|30px|30px|true|true” animation_style=”zoom” animation_intensity_zoom=”8%” border_radii=”on|10px|10px|10px|10px” border_radii_image=”on|4px|4px|4px|4px” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_hover_color=”#f73145″ global_colors_info=”{}” icon_color__hover=”#f73145″ icon_color__hover_enabled=”on”]<\/p>\n
University Hospital in Motol<\/p>\n
[\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”doc. MUDr. Ing. Jakub Cvek, Ph.D.” position=”Head of the Oncology Clinic ” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/11\/Cvek-1.jpg” icon_color=”#f88590″ _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” text_orientation=”center” custom_margin=”||0px|” custom_padding=”30px|30px|30px|30px|true|true” animation_style=”zoom” animation_delay=”100ms” animation_intensity_zoom=”8%” border_radii=”on|10px|10px|10px|10px” border_radii_image=”on|4px|4px|4px|4px” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_hover_color=”#f73145″ locked=”off” global_colors_info=”{}” icon_color__hover=”#f73145″ icon_color__hover_enabled=”on”]<\/p>\n
University Hospital Ostrava<\/p>\n
[\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”MUDr. Michal Eid” position=”Doctor of the Internal Hematology and Oncology Clinic ” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/11\/Eid-1.jpg” icon_color=”#f88590″ _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” text_orientation=”center” custom_margin=”||0px|” custom_padding=”30px|30px|30px|30px|true|true” animation_style=”zoom” animation_delay=”200ms” animation_intensity_zoom=”8%” border_radii=”on|10px|10px|10px|10px” border_radii_image=”on|4px|4px|4px|4px” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_hover_color=”#f73145″ locked=”off” global_colors_info=”{}” icon_color__hover=”#f73145″ icon_color__hover_enabled=”on”]<\/p>\n
University Hospital Brno<\/p>\n
[\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”prof. MUDr. Jind\u0159ich F\u00ednek, Ph.D. ” position=”Head of the Oncology and Radiotherapy Clinic” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/11\/Finek-1.jpg” icon_color=”#f88590″ _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” text_orientation=”center” custom_margin=”||0px|” custom_padding=”30px|30px|30px|30px|true|true” animation_style=”zoom” animation_delay=”300ms” animation_intensity_zoom=”8%” border_radii=”on|10px|10px|10px|10px” border_radii_image=”on|4px|4px|4px|4px” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_hover_color=”#f73145″ locked=”off” global_colors_info=”{}” icon_color__hover=”#f73145″ icon_color__hover_enabled=”on”]<\/p>\n
University Hospital Pilsen<\/p>\n
[\/et_pb_team_member][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ use_custom_gutter=”on” module_class=”equal-boxes” _builder_version=”4.27.4″ max_width=”1440px” custom_padding=”|||” custom_css_free_form=”.equal-boxes {|| display: flex;||}||||.equal-boxes > .et_pb_column {|| display: flex;||}||||.equal-boxes .et_pb_module {|| height: 100%;||}||” use_custom_width=”on” custom_width_px=”1440px” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”MUDr. Jana Katolick\u00e1, Ph.D.” position=”Head of the Oncology and Surgery Department” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/11\/Katolicka-1.jpg” icon_color=”#f88590″ _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” text_orientation=”center” custom_margin=”||0px|” custom_padding=”30px|30px|30px|30px|true|true” animation_style=”zoom” animation_intensity_zoom=”8%” border_radii=”on|10px|10px|10px|10px” border_radii_image=”on|4px|4px|4px|4px” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_hover_color=”#f73145″ global_colors_info=”{}” icon_color__hover=”#f73145″ icon_color__hover_enabled=”on”]<\/p>\n
St. Anne’s University Hospital in Brno <\/p>\n
[\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”doc. MUDr. Kate\u0159ina Kope\u010dkov\u00e1, Ph.D.” position=”Doctor, Oncology Clinic” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/11\/Kopeckova-1.jpg” icon_color=”#f88590″ _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” text_orientation=”center” custom_margin=”||0px|” custom_padding=”30px|30px|30px|30px|true|true” animation_style=”zoom” animation_delay=”100ms” animation_intensity_zoom=”8%” border_radii=”on|10px|10px|10px|10px” border_radii_image=”on|4px|4px|4px|4px” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_hover_color=”#f73145″ locked=”off” global_colors_info=”{}” icon_color__hover=”#f73145″ icon_color__hover_enabled=”on”]<\/p>\n
University Hospital in Motol<\/p>\n
[\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”doc. MUDr. Radka Lohynsk\u00e1, Ph.D.” position=”Head of the Oncology Clinic” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/11\/Lohynska.jpg” icon_color=”#f88590″ _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” text_orientation=”center” custom_margin=”||0px|” custom_padding=”30px|30px|30px|30px|true|true” animation_style=”zoom” animation_delay=”200ms” animation_intensity_zoom=”8%” border_radii=”on|10px|10px|10px|10px” border_radii_image=”on|4px|4px|4px|4px” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_hover_color=”#f73145″ locked=”off” global_colors_info=”{}” icon_color__hover=”#f73145″ icon_color__hover_enabled=”on”]<\/p>\n
Thomayer University Hospital<\/p>\n
[\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_team_member name=”prof. MUDr. Bohuslav Melichar, Ph.D. ” position=”Head of the Oncology Clinic” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/11\/Melichar-1.jpg” icon_color=”#f88590″ _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” text_orientation=”center” custom_margin=”||0px|” custom_padding=”30px|30px|30px|30px|true|true” animation_style=”zoom” animation_delay=”300ms” animation_intensity_zoom=”8%” border_radii=”on|10px|10px|10px|10px” border_radii_image=”on|4px|4px|4px|4px” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_hover_color=”#f73145″ locked=”off” global_colors_info=”{}” icon_color__hover=”#f73145″ icon_color__hover_enabled=”on”]<\/p>\n
University Hospital Olomouc<\/p>\n
[\/et_pb_team_member][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ use_custom_gutter=”on” module_class=”equal-boxes” _builder_version=”4.27.4″ max_width=”1440px” custom_padding=”|||” custom_css_free_form=”.equal-boxes {|| display: flex;||}||||.equal-boxes > .et_pb_column {|| display: flex;||}||||.equal-boxes .et_pb_module {|| height: 100%;||}||” use_custom_width=”on” custom_width_px=”1440px” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”doc. MUDr. Michal Vo\u010dka, Ph.D.” position=”Head of the Oncology Clinic” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/11\/Vocka-1.jpg” icon_color=”#f88590″ _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” text_orientation=”center” custom_margin=”||0px|” custom_padding=”30px|30px|30px|30px|true|true” animation_style=”zoom” animation_intensity_zoom=”8%” border_radii=”on|10px|10px|10px|10px” border_radii_image=”on|4px|4px|4px|4px” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_hover_color=”#f73145″ global_colors_info=”{}” icon_color__hover=”#f73145″ icon_color__hover_enabled=”on”]<\/p>\n
General University Hospital in Prague<\/p>\n
[\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”prof. MUDr. Renata Soumarov\u00e1, Ph.D., MBA ” position=”Head of the Oncology Clinic” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/11\/Soumarova-1.jpg” icon_color=”#f88590″ _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” text_orientation=”center” custom_margin=”||0px|” custom_padding=”30px|30px|30px|30px|true|true” animation_style=”zoom” animation_delay=”100ms” animation_intensity_zoom=”8%” border_radii=”on|10px|10px|10px|10px” border_radii_image=”on|4px|4px|4px|4px” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_hover_color=”#f73145″ locked=”off” global_colors_info=”{}” icon_color__hover=”#f73145″ icon_color__hover_enabled=”on”]<\/p>\n
Kr\u00e1lovsk\u00e9 Vinohrady University Hospital<\/p>\n
[\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”doc. MUDr. Milan Vo\u0161mik, Ph.D.” position=”Head of the Department of Oncology and Radiotherapy” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/11\/Vosmik-1.jpg” icon_color=”#f88590″ _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” text_orientation=”center” custom_margin=”||0px|” custom_padding=”30px|30px|30px|30px|true|true” animation_style=”zoom” animation_delay=”200ms” animation_intensity_zoom=”8%” border_radii=”on|10px|10px|10px|10px” border_radii_image=”on|4px|4px|4px|4px” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_hover_color=”#f73145″ locked=”off” global_colors_info=”{}” icon_color__hover=”#f73145″ icon_color__hover_enabled=”on”]<\/p>\n
University Hospital Hradec Kr\u00e1lov\u00e9<\/p>\n
[\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”54px|auto||auto||” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_heading title=”Members” _builder_version=”4.27.4″ _module_preset=”default” title_level=”h3″ global_colors_info=”{}”][\/et_pb_heading][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
The members of the CZECRIN | ONCO<\/strong> network represent an active professional community that connects academic and clinical institutions involved in cancer research in the Czech Republic. Unlike the members of the disciplinary council, who are dedicated to the strategic and conceptual direction of research, the members of the network focus primarily on the practical implementation of clinical trials – from protocol design and centre involvement to data collection and sharing of results. <\/p>\nTheir activities are crucial for the transfer of scientific knowledge into clinical practice, the development of collaboration between centres and the strengthening of academic research infrastructure in oncology. CZECRIN | ONCO<\/strong> members also act as ambassadors of the network in their institutions and contribute to the development of academic clinical research and the visibility of the Czech oncology community in the international context. <\/p>\nThe CZECRIN | ONCO<\/strong> network consists of experts from all over the Czech Republic who are involved in the development of academic clinical research in oncology.
Their common goal is to link research with clinical practice and to support the implementation of national and international clinical trials.<\/p>\n[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”|auto|29px|auto||” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_heading title=”Project Management” _builder_version=”4.27.4″ _module_preset=”default” title_level=”h3″ global_colors_info=”{}”][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ module_class=”equal-boxes” _builder_version=”4.27.4″ _module_preset=”default” min_height=”254.6px” custom_margin=”-19px|auto||auto||” custom_css_free_form=”.equal-boxes {|| display: flex;||}||||.equal-boxes > .et_pb_column {|| display: flex;||}||||.equal-boxes .et_pb_module {|| height: 100%;||}||” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_team_member name=”Mgr. Martina Lojov\u00e1, Ph.D. ” position=”Project Manager CZECRIN | ONCO” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/10\/Lojova_2.jpg” _builder_version=”4.27.4″ _module_preset=”default” header_font_size=”20px” transform_scale=”80%|80%” custom_margin=”||-4px|||” global_colors_info=”{}”]<\/p>\n
martina.lojova@mou.cz<\/a>
543 13 6232<\/strong><\/p>\n[\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_team_member name=”PharmDr. Kl\u00e1ra Chrom\u00e1 Ku\u010derov\u00e1 ” position=”GENESIS Project Manager” _builder_version=”4.27.4″ _module_preset=”default” header_font_size=”20px” transform_scale=”80%|80%” custom_margin=”||-4px|||” global_colors_info=”{}”]<\/p>\n
klara.chroma@<\/obfus-first>mou.cz<\/obfus-second><\/span><\/a>
543 13 6239<\/strong><\/p>\n[\/et_pb_team_member][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|phone” admin_label=”Hiring” _builder_version=”4.27.4″ background_color=”#ffffff” use_background_color_gradient=”on” background_color_gradient_stops=”#ffffff 0%|rgba(41,196,169,0.3) 72%|rgba(42,164,194,0.7) 93%” background_size=”initial” custom_margin=”|||” custom_margin_tablet=”” custom_margin_phone=”” custom_margin_last_edited=”on|phone” custom_padding=”19px|||||” custom_padding_tablet=”|||” custom_padding_phone=”|||” top_divider_style=”asymmetric” top_divider_color=”#FFFFFF” top_divider_height=”226px” top_divider_flip=”vertical” bottom_divider_style=”ramp” bottom_divider_color=”#ffffff” bottom_divider_height=”200px” bottom_divider_flip=”horizontal” saved_tabs=”all” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_heading title=”Collaboration” _builder_version=”4.27.4″ _module_preset=”default” title_level=”h2″ global_colors_info=”{}”][\/et_pb_heading][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
CZECRIN | ONCO <\/strong>creates a space where clinical research, diagnostics and clinical care are linked through the support and development of academic clinical trials in the Czech Republic.<\/p>\nThe platform provides a methodological, coordinating and organizational background for collaboration between research teams, clinical sites and diagnostic centres. It supports data sharing, process harmonisation and patient involvement in research activities in line with clinical research principles, including in the field of personalised medicine. <\/p>\n
CZECRIN | ONCO<\/strong> thus creates an interconnected infrastructure that strengthens clinical research, enables efficient transfer of knowledge into practice and supports the implementation of innovative approaches in oncology.<\/p>\n[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ use_custom_gutter=”on” make_equal=”on” _builder_version=”4.27.4″ width=”89%” custom_padding=”|||” use_custom_width=”on” custom_width_px=”1440px” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_blurb title=”Centre for Precision Oncology ” url=”#top” use_icon=”on” font_icon=”||fa||900″ icon_color=”#6a9ae8″ image_icon_background_color=”rgba(106,154,232,0.3)” image_icon_width=”45px” icon_alignment=”left” _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_text_align=”left” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” image_icon_custom_padding=”25px|25px|25px|25px|false|false” text_orientation=”center” module_alignment=”left” custom_margin=”||0px|” custom_padding=”30px|20px|40px|20px|false|true” custom_padding_tablet=”” custom_padding_phone=”” custom_padding_last_edited=”on|phone” animation_style=”zoom” animation_intensity_zoom=”8%” animation=”off” border_radii=”on|10px|10px|10px|10px” border_width_all=”20px” border_color_all=”#ffffff” border_width_top=”20px” border_color_top=”#ffffff” border_width_right=”20px” border_color_right=”#ffffff” border_width_bottom=”20px” border_color_bottom=”#ffffff” border_width_left=”20px” border_color_left=”#ffffff” border_radii_image=”on|100%|100%|100%|100%” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_font_size=”32px” use_circle=”on” circle_color=”rgba(106,154,232,0.3)” global_colors_info=”{}” image_icon_background_color__sticky_enabled=”#263077″ image_icon_background_color__sticky=”#263077″]<\/p>\n
The Centre of Precision Oncology of the Masaryk Cancer Institute (MO\u00da) is a professional and technological base<\/strong> for molecular genetic testing of solid tumours in patients from the Czech Republic.<\/p>\nIt has state-of-the-art facilities for molecular diagnostics and bioinformatics and provides:<\/p>\n
\n- molecular diagnostics and sequencing,<\/li>\n
- bioinformatics analysis and data interpretation,<\/li>\n<\/ul>\n
that form the basis of a personalised approach to the treatment of solid tumours.
The Centre for Precision Oncology cooperates closely with the University Hospital Brno, both with the Internal Hematology and Oncology Clinic and the Clinic of Paediatric Oncology.<\/p>\n
[\/et_pb_blurb][et_pb_button button_url=”https:\/\/www.mou.cz\/centrum-precizni-onkologie\/t1325″ url_new_window=”on” button_text=”More information” button_alignment=”center” _builder_version=”4.27.4″ custom_button=”on” button_text_size=”14px” button_text_color=”#10275D” button_bg_color=”#ffffff” button_bg_color_gradient_direction=”90deg” button_bg_color_gradient_stops=”#f7828e 0%|#fcb6ab 100%” button_bg_color_gradient_start=”#f7828e” button_bg_color_gradient_end=”#fcb6ab” button_border_width=”0px” button_border_color=”rgba(0,0,0,0)” button_border_radius=”4px” button_letter_spacing=”5px” button_font=”Roboto|700||on|||||” button_use_icon=”off” background_layout=”dark” custom_margin=”-10px|||” custom_padding=”10px|20px|10px|20px|true|true” animation_style=”zoom” animation_intensity_zoom=”8%” box_shadow_style=”preset1″ box_shadow_blur=”30px” box_shadow_color=”rgba(110,130,208,0.14)” button_text_color_hover=”#7a69e6″ button_letter_spacing_hover=”8px” global_colors_info=”{}” button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”on” button_text_color__hover=”#7a69e6″ button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”on” button_letter_spacing__hover=”8px” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_button][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_blurb title=”Project GENESIS Czech Republic” url=”#genesis” use_icon=”on” font_icon=”||fa||900″ icon_color=”#f767b4″ image_icon_background_color=”rgba(247,103,180,0.3)” image_icon_width=”45px” icon_alignment=”left” _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_text_align=”left” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” image_icon_custom_padding=”25px|25px|25px|25px|false|false” text_orientation=”center” module_alignment=”left” custom_margin=”||0px|” custom_padding=”30px|20px|40px|20px|false|true” custom_padding_tablet=”” custom_padding_phone=”” custom_padding_last_edited=”on|phone” animation_style=”zoom” animation_intensity_zoom=”8%” animation=”off” border_radii=”on|10px|10px|10px|10px” border_width_all=”20px” border_color_all=”#ffffff” border_width_top=”20px” border_color_top=”#ffffff” border_width_right=”20px” border_color_right=”#ffffff” border_width_bottom=”20px” border_color_bottom=”#ffffff” border_width_left=”20px” border_color_left=”#ffffff” border_radii_image=”on|100%|100%|100%|100%” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_font_size=”32px” use_circle=”on” circle_color=”rgba(247,103,180,0.3)” global_colors_info=”{}” image_icon_background_color__sticky_enabled=”#263077″ image_icon_background_color__sticky=”#263077″]<\/p>\n
The GENESIS project establishes the framework of the Czech National Molecular Tumour Board Platform<\/strong> and the Czech National Precision Medicine Network<\/strong>, which connect diagnostic, research and clinical teams across the country.<\/p>\nGENESIS thus provides a comprehensive source of clinical and molecular data<\/strong> that is useful for both scientific research<\/strong> and practical clinical decision support<\/strong>.<\/p>\nThe Centre for Precision Oncology is an expert partner of the GENESIS project<\/strong> and provides its technological, bioinformatics and analytical background.
Together they contribute to the development of data-driven personalised oncology in the Czech Republic<\/strong>.<\/p>\n[\/et_pb_blurb][et_pb_button button_url=”#genesis” button_text=”o GENESIS” button_alignment=”center” _builder_version=”4.27.4″ custom_button=”on” button_text_size=”14px” button_text_color=”#10275D” button_bg_color=”#ffffff” button_bg_color_gradient_direction=”90deg” button_bg_color_gradient_stops=”#f7828e 0%|#fcb6ab 100%” button_bg_color_gradient_start=”#f7828e” button_bg_color_gradient_end=”#fcb6ab” button_border_width=”0px” button_border_color=”rgba(0,0,0,0)” button_border_radius=”4px” button_letter_spacing=”5px” button_font=”Roboto|700||on|||||” button_use_icon=”off” custom_margin=”-10px|||” custom_padding=”10px|20px|10px|20px|true|true” animation_style=”zoom” animation_intensity_zoom=”8%” box_shadow_style=”preset1″ box_shadow_blur=”30px” box_shadow_color=”rgba(110,130,208,0.14)” button_text_color_hover=”#7a69e6″ button_letter_spacing_hover=”8px” global_colors_info=”{}” button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”on” button_text_color__hover=”#7a69e6″ button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”on” button_letter_spacing__hover=”8px” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_button][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_blurb title=”Molecular Tumor Board ” url=”#top” use_icon=”on” font_icon=”||fa||900″ icon_color=”#f98d5e” image_icon_background_color=”rgba(249,141,94,0.3)” image_icon_width=”45px” icon_alignment=”left” _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_text_align=”left” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” image_icon_custom_padding=”25px|25px|25px|25px|false|false” text_orientation=”center” module_alignment=”left” custom_margin=”||0px|” custom_padding=”30px|20px|40px|20px|false|true” custom_padding_tablet=”” custom_padding_phone=”” custom_padding_last_edited=”on|phone” animation_style=”zoom” animation_intensity_zoom=”8%” animation=”off” border_radii=”on|10px|10px|10px|10px” border_width_all=”20px” border_color_all=”#ffffff” border_width_top=”20px” border_color_top=”#ffffff” border_width_right=”20px” border_color_right=”#ffffff” border_width_bottom=”20px” border_color_bottom=”#ffffff” border_width_left=”20px” border_color_left=”#ffffff” border_radii_image=”on|100%|100%|100%|100%” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_font_size=”32px” use_circle=”on” circle_color=”rgba(249,141,94,0.3)” global_colors_info=”{}” image_icon_background_color__sticky_enabled=”#263077″ image_icon_background_color__sticky=”#263077″]<\/p>\n
The Molecular Tumor Board (MTB) is a multidisciplinary expert forum<\/strong> that clinically interprets data from the Precision Oncology Center and the GENESIS project and translates it into treatment decision-making.<\/p>\nIt brings together clinical oncologists, pathologists and molecular biologists, geneticists, bioinformaticians, pharmacologists and other experts who:<\/p>\n
\n- assess individual treatment options,<\/li>\n
- recommend targeted therapy or an appropriate clinical trial,<\/li>\n
- ensure the transfer of research findings into clinical practice, i.e. real oncological care for patients with solid tumours.<\/li>\n<\/ul>\n
MTB thus represents a key bridge between laboratory diagnostics and clinical decision-making.<\/strong><\/p>\n[\/et_pb_blurb][et_pb_button button_url=”https:\/\/www.muni.cz\/en\/research\/publications\/1502717″ url_new_window=”on” button_text=”more information” button_alignment=”center” _builder_version=”4.27.4″ custom_button=”on” button_text_size=”14px” button_text_color=”#10275D” button_bg_color=”#ffffff” button_bg_color_gradient_direction=”90deg” button_bg_color_gradient_stops=”#f7828e 0%|#fcb6ab 100%” button_bg_color_gradient_start=”#f7828e” button_bg_color_gradient_end=”#fcb6ab” button_border_width=”0px” button_border_color=”rgba(0,0,0,0)” button_border_radius=”4px” button_letter_spacing=”5px” button_font=”Roboto|700||on|||||” button_use_icon=”off” background_layout=”dark” custom_margin=”-10px|||” custom_padding=”10px|20px|10px|20px|true|true” animation_style=”zoom” animation_intensity_zoom=”8%” box_shadow_style=”preset1″ box_shadow_blur=”30px” box_shadow_color=”rgba(110,130,208,0.14)” button_text_color_hover=”#7a69e6″ button_letter_spacing_hover=”8px” global_colors_info=”{}” button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”on” button_text_color__hover=”#7a69e6″ button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”on” button_letter_spacing__hover=”8px” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” background_enable_image=”off” background_size=”contain” background_position=”center_right” background_horizontal_offset=”4%” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
Every new treatment is built on a clinical trial, and many of these are supported by CZECRIN. <\/h3>\n
Before a new medicine reaches patients, it must go through a long and carefully regulated clinical research pathway. CZECRIN connects clinical sites, research teams, and data to ensure that clinical trials are meaningfully designed, conducted to high quality standards, and deliver real benefits for patients \u2014 both in the Czech Republic and across Europe. <\/p>\n
Featured in the video:<\/p>\n
\n- \n
Regina Demlov\u00e1, Director of the Centre of Excellence CREATIC<\/strong> and CZECRIN<\/p>\n<\/li>\n- \n
Jaroslav \u0160t\u011brba<\/strong>, Head of the Department of Paediatric Oncology, University Hospital Brno<\/span><\/p>\n<\/li>\n- \n
Radka Lordick Obermannov\u00e1<\/strong>, Head of the Department of Clinical Trials, Masaryk Memorial Cancer Institute<\/p>\n<\/li>\n<\/ul>\nOn academic clinical research, the National Institute for Cancer Research (NICR)<\/strong><\/a>, innovative treatment for paediatric patients, and collaboration within ECRIN-ERIC<\/strong>.<\/p>\n[\/et_pb_text][et_pb_video src=”https:\/\/youtu.be\/t7M0p0oZkL8?si=kuYhtBl-tf98OjNq” image_src=”\/\/i.ytimg.com\/vi\/t7M0p0oZkL8\/hqdefault.jpg” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_video][et_pb_button button_url=”https:\/\/czecrin.cz\/en\/behind-every-new-treatment-is-a-clinical-trial-and-behind-many-of-them-is-czecrin\/” url_new_window=”on” button_text=”Read more” button_alignment=”left” _builder_version=”4.27.4″ _module_preset=”5a18c15d-02ca-4e50-a6c0-9677dd27deba” global_colors_info=”{}”][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.27.4″ _module_preset=”default” custom_padding=”12px|||||” top_divider_color=”#d3e5ff” top_divider_style_last_edited=”off|desktop” bottom_divider_style=”asymmetric” bottom_divider_color=”#54a2e3″ global_colors_info=”{}”][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|phone” admin_label=”Klinick\u00e9 studie a v\u00fdzkumn\u00e9 projekty” module_id=”study_onco” _builder_version=”4.27.4″ background_color=”#f2f2fa” use_background_color_gradient=”on” background_color_gradient_stops=”#ffffff 0%|#f2f2fa 50%” background_color_gradient_start=”#ffffff” background_color_gradient_end=”#f2f2fa” background_color_gradient_end_position=”50%” background_size=”initial” z_index=”99″ overflow-x=”visible” overflow-y=”visible” custom_margin=”|||” custom_margin_tablet=”” custom_margin_phone=”” custom_margin_last_edited=”on|phone” custom_padding=”2px|||||” custom_padding_tablet=”|||” custom_padding_phone=”|||” bottom_divider_style=”ramp” bottom_divider_color=”#ffffff” bottom_divider_height=”200px” bottom_divider_flip=”horizontal” saved_tabs=”all” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.4″ custom_padding=”95px|||||” locked=”off” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_heading title=”Clinical trials and research projects” _builder_version=”4.27.4″ _module_preset=”default” title_level=”h2″ global_colors_info=”{}”][\/et_pb_heading][et_pb_text _builder_version=”4.27.4″ text_font=”||||||||” text_font_size=”16px” ul_font=”||||||||” header_font=”||||||||” header_2_font=”Roboto|700|||||||” header_2_font_size=”45px” header_2_line_height=”1.2em” header_3_font=”||||||||” text_orientation=”center” max_width_last_edited=”off|desktop” module_alignment=”center” custom_margin=”|||” custom_padding=”|||” header_2_font_size_tablet=”35px” header_2_font_size_phone=”28px” header_2_font_size_last_edited=”on|phone” global_colors_info=”{}”]<\/p>\n
CZECRIN | ONCO<\/strong> collaborates on clinically relevant projects focused on the diagnosis, treatment and prevention of solid tumours, while supporting education and the development of the research environment in its field. Our goal is to ensure that patients with solid tumors have access to personalized and innovative diagnostics, treatment and prevention through well-designed and implemented academic clinical trials. <\/p>\n[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” border_style_all=”none” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_heading title=”Ongoing clinical trials” _builder_version=”4.27.4″ _module_preset=”default” title_level=”h3″ global_colors_info=”{}”][\/et_pb_heading][et_pb_tabs active_tab_background_color=”#2B87DA” active_tab_text_color=”#FFFFFF” module_id=”genesis” _builder_version=”4.27.4″ _module_preset=”default” tab_text_color=”#000000″ tab_letter_spacing=”2px” tab_line_height=”2.7em” custom_margin=”5px|5px|5px|5px|false|false” custom_padding=”5px|10px|5px|10px|false|false” border_radii=”on|10px|10px|10px|10px” border_width_all=”0px” border_color_all=”#2B87DA” box_shadow_style=”preset1″ global_colors_info=”{}”][et_pb_tab title=”GastroPET II” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
Name<\/span><\/strong><\/strong><\/strong><\/p>\n\n- GastroPET II; <\/strong>Sequential FDG-PET and miRNA as a biomarker of change in preoperative treatment strategy in locally advanced gastric and gastroesophageal junction cancer – a follow-up study<\/li>\n<\/ul>\n
Design<\/span><\/strong><\/p>\n\n- Non-interventional academic clinical follow-up study<\/li>\n<\/ul>\n
Diagnosis<\/strong><\/span><\/p>\n\n- Patients with locally advanced resectable adenocarcinoma of the oesophagus and stomach (Siewert I – III) with T3N0, T4N0, T2 – T4N+, stage Ib – IIIc with indication for FOLFOX or FLOT treatment previously enrolled in KH GastroPET<\/li>\n<\/ul>\n
Description<\/strong><\/span><\/p>\n\n- The aim of this follow-up study is non-interventional follow-up of the secondary endpoints of KH LP GastroPET in the population of enrolled patients, namely the predictive values of PET for disease free survival (DFS) and overall survival (OS) in individual arms defined by the KH LP GastroPET protocol.<\/li>\n<\/ul>\n
Contact<\/span>
<\/strong><\/p>\n\n- Contracting authority: the Masaryk Institute of Oncology<\/a><\/li>\n
- Leading Investigator: doc. MUDr. Radka Lordick Obermannov\u00e1, Ph.D.<\/a><\/li>\n<\/ul>\n
Centres in the Czech Republic<\/strong><\/span><\/p>\n\n- Masaryk Institute of Oncology; PI: doc. MUDr. Radka Lordick Obermannov\u00e1, Ph.D.<\/li>\n
- General University Hospital in Prague; PI: doc. MUDr. Milada Zemanov\u00e1, Ph.D.<\/li>\n
- University Hospital Olomouc; PI: doc. MUDr. Hana Studentov\u00e1, Ph.D.<\/li>\n<\/ul>\n
[\/et_pb_tab][et_pb_tab title=”GENESIS” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
Name<\/span><\/strong><\/p>\n\n- GENESIS<\/strong>, Genomic Alterations Platform for Next Clinical Studies
National e-platform for molecular tumor boards<\/li>\n<\/ul>\nStatus<\/strong><\/span><\/p>\n\n- Active recruitment<\/span><\/span><\/li>\n<\/ul>\n
Description<\/strong><\/span><\/p>\n\n- Genesis is a multicentre project of a consortium of ten clinical oncology centres with an active molercular tumour board in the Czech Republic. The project is an integral part of an innovative approach to the treatment of malignant diseases, called precision oncology, which adapts therapy to the individual characteristics of the patient and his tumour. <\/li>\n<\/ul>\n
Objectives<\/strong><\/span><\/p>\n\n- harmonisation of indications for genomic testing,<\/li>\n
- harmonization of individual molecular tumor board outputs,<\/li>\n
- Data collection and sharing, analysis of the effectiveness of molecularly-genomically targeted therapies,<\/li>\n
- cost-effectiveness analyses of different treatment approaches, etc.<\/li>\n<\/ul>\n
International cooperation and partnerships<\/strong><\/span><\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ fullwidth=”on” admin_label=”Co je CZECRIN ONCO” _builder_version=”4.27.4″ collapsed=”off” global_colors_info=”{}” box_shadow_style__hover=”none” box_shadow_style__hover_enabled=”none” box_shadow_color__hover=”rgba(0,0,0,0.3)” box_shadow_color__hover_enabled=”rgba(0,0,0,0.3)”][et_pb_fullwidth_header title=”CZECRIN | ONCO is an industry-oriented network” text_orientation=”center” header_fullscreen=”on” button_two_text=”We want to be part of CZECRIN | ONCO” button_two_url=”” background_overlay_color=”rgba(113,216,255,0.22)” _builder_version=”4.27.4″ title_font=”Faustina|600|||||||” title_font_size=”40px” title_line_height=”1.4em” content_font=”||||||||” background_enable_color=”off” background_image=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/10\/CZECRIN-onco.jpg” background_position=”center_left” custom_button_one=”on” button_one_text_size=”14px” button_one_text_color=”#ffffff” button_one_bg_color=”#26c699″ button_one_border_width=”8px” button_one_border_color=”rgba(0,0,0,0)” button_one_letter_spacing=”1px” button_one_font=”|700||on|||||” custom_button_two=”on” button_two_text_size=”16px” button_two_text_color=”#FFFFFF” button_two_bg_color=”rgba(29,52,96,0.6)” button_two_border_width=”0px” button_two_border_color=”#263077″ button_two_letter_spacing=”1px” button_two_font=”|700||on|||||” button_two_icon=”||divi||400″ button_two_icon_color=”#F2F8FF” button_two_icon_placement=”left” custom_margin=”|||||false” custom_padding=”10vw||10vw||true” link_option_url_new_window=”on” title_font_size_tablet=”32px” title_font_size_phone=”22px” title_font_size_last_edited=”on|desktop” button_two_text_shadow_style=”preset1″ box_shadow_style_button_two=”preset1″ global_colors_info=”{}”]<\/p>\n
which aims to support the design, implementation and development of academic clinical trials in this area – from protocol design to the implementation of results into clinical practice. It was established in 2020 to systematically support academic clinical research in the field of solid tumours. It responds to the specific patient needs and challenges of this rapidly evolving field. <\/p>\n
<\/p>\n
The CZECRIN | ONCO network connects cancer centres, research teams and clinical experts who want to actively participate in academic and sponsored clinical trials in the field of oncology. If you are interested in collaborating or joining the network, please fill out the following form. <\/p>\n
<\/p>\n
[\/et_pb_fullwidth_header][et_pb_fullwidth_image _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_fullwidth_image][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|phone” admin_label=”Mapa” _builder_version=”4.27.4″ background_color=”#f2f2fa” use_background_color_gradient=”on” background_color_gradient_stops=”#ffffff 0%|#f2f2fa 50%” background_color_gradient_start=”#ffffff” background_color_gradient_end=”#f2f2fa” background_color_gradient_end_position=”50%” background_size=”initial” z_index=”99″ overflow-x=”visible” overflow-y=”visible” custom_margin=”|||” custom_margin_tablet=”” custom_margin_phone=”” custom_margin_last_edited=”on|phone” custom_padding=”|||” custom_padding_tablet=”|||” custom_padding_phone=”|||” bottom_divider_style=”ramp” bottom_divider_color=”#ffffff” bottom_divider_height=”200px” bottom_divider_flip=”horizontal” saved_tabs=”all” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_heading title=”Connected centres in the CZECRIN DONET network | ONCO” _builder_version=”4.27.4″ _module_preset=”default” title_level=”h2″ global_colors_info=”{}”][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.4″ locked=”off” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.27.4″ text_font=”||||||||” text_font_size=”16px” ul_font=”||||||||” header_font=”||||||||” header_2_font=”Roboto|700|||||||” header_2_font_size=”45px” header_2_line_height=”1.2em” header_3_font=”||||||||” text_orientation=”center” max_width_last_edited=”off|desktop” module_alignment=”center” custom_margin=”|||” custom_padding=”|||” header_2_font_size_tablet=”35px” header_2_font_size_phone=”28px” header_2_font_size_last_edited=”on|phone” global_colors_info=”{}”]<\/p>\n
The DONET network CZECRIN | ONCO<\/strong> includes sites across the Czech Republic that share know-how, coordinate research activities and contribute to strengthening the quality of independent studies in the field. All centres collaborate on the GENESIS<\/a><\/strong> project .<\/strong> <\/p>\n <\/strong><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.27.4″ _module_preset=”default” custom_padding=”20px|20px|20px|20px|false|false” border_radii=”on|10px|10px|10px|10px” box_shadow_style=”preset1″ box_shadow_blur=”12px” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_map address=”Palachovo n\u00e1m. 726\/2, 625 00 Brno-Star\u00fd L\u00edskovec, \u010cesko” zoom_level=”6″ address_lat=”49.758883197778″ address_lng=”15.432271904983″ _builder_version=”4.27.4″ _module_preset=”default” background_enable_color=”off” animation_style=”slide” link_option_url_new_window=”on” hover_enabled=”0″ box_shadow_style=”preset1″ global_colors_info=”{}” sticky_enabled=”0″][et_pb_map_pin title=”Fakultn\u00ed nemocnice u\u00a0sv.\u00a0Anny v\u00a0Brn\u011b” pin_address=”Peka\u0159sk\u00e1 664\/53, 656 91 Brno-st\u0159ed, \u010cesko” pin_address_lat=”49.191327″ pin_address_lng=”16.5993373″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n Centre for Clinical Studies St. Anne’s Hospital in Brno <\/strong> is an important partner for CZECRIN, providing complete support for clinical trials in the hospital. It coordinates all processes, communicates with sponsors of commercial studies and participates in the implementation of academic projects. At the same time, it acts as a point of contact for patients and volunteers. The centre assists with the preparation of documentation for regulatory authorities, contracting with partner centres and monitoring studies, thus ensuring the quality and safe conduct of clinical trials. <\/p>\n St. Anne’s University Hospital in Brno – homepage | FNUSA <\/a><\/strong><\/p>\n Centre for Clinical Studies | FNUSA<\/a><\/strong><\/p>\n MUDr. Jana Katolick\u00e1, Ph.D.<\/strong> [\/et_pb_map_pin][et_pb_map_pin title=”Masaryk Institute of Oncology” pin_address=”656 53, \u017dlut\u00fd kopec 543\/7, 602 00 Brno-st\u0159ed-Star\u00e9 Brno, \u010cesko” pin_address_lat=”49.1948263″ pin_address_lng=”16.5891581″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n The Masaryk Institute of Oncology (MO\u00da)<\/b> is a key partner of the CZECRIN network. It is home to the first Centre for Precision Oncology in the Czech Republic, which in cooperation with CZECRIN established the GENESIS<\/b> project. This national platform aims to unify procedures, share data and analyse the effectiveness of modern targeted therapies across the Czech Republic. The Centre is also actively involved in recruiting patients for clinical trials. <\/p>\n You can read more about precision oncology here.<\/a><\/p>\n [\/et_pb_map_pin][et_pb_map_pin title=”University Hospital Brno” pin_address=”Jihlavsk\u00e1 340\/20, 625 00 Brno-Star\u00fd L\u00edskovec, \u010cesko” pin_address_lat=”49.1753832″ pin_address_lng=”16.5695055″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n The Clinical Trials Department of the Brno University Hospital<\/strong>, which falls under the Office of the Deputy Minister for Science and Research, provides administrative support for clinical trials across the hospital’s clinics. The team prepares contracts and budgets with sponsors, controls payments, keeps records of studies and prepares documents for invoicing and cost accounting. Support includes the involvement of OKS study coordinators in specific projects and coordination of the contract negotiation process in collaboration with the Legal Affairs Department. The Unit also manages the CTIS identifiers of the various departments and provides contact support for the contracting authorities and partner centres. <\/p>\n Department of Clinical Studies – University Hospital Brno<\/a><\/p>\n MUDr. Michal Eid<\/strong> [\/et_pb_map_pin][et_pb_map_pin title=”University Hospital Ostrava” pin_address=”5 708, 17. listopadu 1790\/5, 708 00 Ostrava-Poruba, \u010cesko” pin_address_lat=”49.8278637″ pin_address_lng=”18.1620609″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n The Clinical Trials Centre of the Ostrava University Hospital<\/strong> is a key place for initiating and coordinating clinical trials in the hospital. It serves as a link between study sponsors and investigators, ensuring fast, accurate and efficient communication. It enters the process as an administrative, financial and control authority and no clinical trial can be implemented at FNO without its approval. Its main objective is to simplify and speed up all processes related to the conduct of studies. Since 2016, FN Ostrava has been part of the national research infrastructure CZECRIN, which supports academic clinical trials and operates in connection with the European ECRIN network. <\/p>\n Centre for Clinical Studies (CKS) | University Hospital Ostrava<\/a><\/p>\n doc. MUDr. Ing. Jakub Cvek, Ph.D.<\/strong> [\/et_pb_map_pin][et_pb_map_pin title=”University Hospital Hradec Kr\u00e1lov\u00e9” pin_address=”Sokolsk\u00e1 581, 500 05 Hradec Kr\u00e1lov\u00e9-Nov\u00fd Hradec Kr\u00e1lov\u00e9, \u010cesko” pin_address_lat=”50.1979291″ pin_address_lng=”15.8263686″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n The Hradec Kr\u00e1lov\u00e9<\/strong> University Hospital<\/strong> offers its partners comprehensive cooperation in the field of clinical evaluation of drugs and medical devices, which it provides at the level of a top medical facility with modern equipment and experienced experts. In recent years, the interest in the implementation of studies has been growing significantly, especially in the fields of oncology, hematology and neurology, but the hospital has long been a reliable partner in internal medicine and surgery. Clinical trials are conducted in accordance with Czech legislation, international standards and ethical principles. In order to start a study, it is necessary to submit complete documentation: from the application and protocol through the approval of the S\u00daKL and the ethics committee to the draft contract with economic calculation and related manuals and forms. <\/p>\n Clinical evaluation of medicines | University Hospital Hradec Kr\u00e1lov\u00e9<\/a><\/p>\n doc. MUDr. Milan Vo\u0161mik, Ph.D.<\/strong> [\/et_pb_map_pin][et_pb_map_pin title=”Thomayer University Hospital” pin_address=”140 59, V\u00edde\u0148sk\u00e1 800, 140 00 Praha 4-Kr\u010d, \u010cesko” pin_address_lat=”50.0294283″ pin_address_lng=”14.4574157″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n Thomayer University Hospital<\/strong> is an active member of the national and European infrastructure CZECRIN, which supports academic clinical research and connects Czech institutions with international projects through the ECRIN-ERIC network. CZECRIN brings together key clinical centres, offers expert capacities for research and development of drugs and medical devices and sets quality standards for processes and data in accordance with FAIR principles. At the same time, it is dedicated to education and competence development in the field of clinical trials, thus strengthening the professional background for the implementation of academic trials throughout the Czech Republic. <\/p>\n Clinical research | Fakultn\u00ed Thomayerova nemocnice<\/a><\/p>\n doc. MUDr. Radka Lohynsk\u00e1, Ph.D.<\/strong> [\/et_pb_map_pin][et_pb_map_pin title=”Motol University Hospital” pin_address=”V \u00davalu 84, 150 06 Praha 5, \u010cesko” pin_address_lat=”50.0734726″ pin_address_lng=”14.3406404″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n The Clinical Trials Department of Motol Hospital<\/strong> provides administrative support for commercial and academic studies conducted at the hospital and works closely with CZECRIN. The Motol Hospital is the venue for clinical trials of drugs and medical devices and academic clinical trials, where the team provides support from submission to the S\u00daKL and ethics committees, through the preparation of synopses and informed consents to the conclusion of contracts with partner centres and monitoring of studies. <\/p>\n Clinical evaluation at Motol University Hospital – Motol University Hospital<\/a><\/p>\n prof. MUDr. Tom\u00e1\u0161 B\u00fcchler, Ph.D. <\/strong> doc. MUDr. Kate\u0159ina Kope\u010dkov\u00e1, Ph.D.<\/strong> [\/et_pb_map_pin][et_pb_map_pin title=”General University Hospital” pin_address=”U Nemocnice 499\/2, 128 08 Praha 2-Nov\u00e9 M\u011bsto, \u010cesko” pin_address_lat=”50.0733909″ pin_address_lng=”14.421015″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n The Clinical Trials and Research Department of the VFN<\/strong> provides comprehensive administrative and professional support in the initiation and implementation of clinical trials. It provides communication with sponsors and CROs, coordinates the start-up phase including legal and economic review of contracts, and links clinics with sites such as laboratories, pharmacy and imaging. It also supports investigator-initiated academic projects (IITs), assists staff with preparation of documents, study billing, payment control and record keeping. The department participates in inspections and audits, coordinates the archiving of documentation, and ensures the payment of travel reimbursements to patients. <\/p>\n Clinical Evaluation and Research – General University Hospital in Prague<\/a><\/p>\n doc. MUDr. Michal Vo\u010dka, Ph.D.<\/strong> [\/et_pb_map_pin][et_pb_map_pin title=”University Hospital Pilsen” pin_address=”E. Bene\u0161e 1128\/13, 301 00 Plze\u0148 3, \u010cesko” pin_address_lat=”49.7319938″ pin_address_lng=”13.3755267″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n The University Hospital Plze\u0148<\/strong> has long been involved in the implementation of clinical trials across a wide spectrum of medical disciplines. As a modern teaching facility with highly specialised facilities, it is involved in both commercial and academic projects and provides the expertise of doctors, study coordinators and specialised departments. Clinical trials are conducted in accordance with current legislation and international standards, with an emphasis on patient safety and the quality of the data obtained. FN Plze\u0148 is dedicated to the development of new drugs and medical devices, as well as to supporting research activities within the national infrastructure CZECRIN and involves hundreds of patients in studies that contribute to the development of modern medicine. <\/p>\n University Hospital Pilsen<\/a><\/p>\n [\/et_pb_map_pin][et_pb_map_pin title=”University Hospital Olomouc” pin_address=”Zdravotn\u00edk\u016f 248\/7, 779 00 Olomouc-Olomouc 9, \u010cesko” pin_address_lat=”49.5859341″ pin_address_lng=”17.2398797″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n Olomouc University Hospital<\/strong> is actively involved in conducting clinical trials of drugs and medical devices across specialist departments. As a modern university centre, it offers the facilities of top clinics, experienced teams of investigators and high-quality technical equipment. Studies are conducted in accordance with national legislation, international standards and ethical principles with an emphasis on patient safety and accuracy of the data obtained. The hospital cooperates with sponsors in the preparation of documentation and contracts and provides expert support throughout the duration of the clinical trial. <\/p>\n Clinical evaluation of medicines and medical devices | University Hospital Olomouc<\/a><\/p>\n prof. MUDr. Bohuslav Melichar, Ph.D. <\/strong> [\/et_pb_map_pin][et_pb_map_pin title=”Kr\u00e1lovsk\u00e9 Vinohrady University Hospital” pin_address=”\u0160rob\u00e1rova 1150\/50, 100 00 Praha 10-Vinohrady, \u010cesko” pin_address_lat=”50.0742053″ pin_address_lng=”14.4764531″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n The Department of the Deputy Director for Science and Research at the Kr\u00e1lovsk\u00e9 Vinohrady Hospital<\/strong> provides comprehensive management of the scientific and research agenda across the hospital. It coordinates the development of science in clinical and laboratory departments, methodically leads research activities and supports the introduction of the most modern treatment procedures. At the same time, it is involved in the preparation and coordination of grant projects at national and international level, ensures the implementation and cooperation in clinical trials and oversees the effective use of funds resulting from the status of a research organisation. The department also includes an Ethics Committee and an Office for International Cooperation in Science and Research. <\/p>\n Kr\u00e1lovsk\u00e9 Vinohrady University Hospital<\/a><\/p>\n prof. MUDr. Renata Soumarov\u00e1, Ph.D., MBA <\/strong> [\/et_pb_map_pin][\/et_pb_map][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n Capital City of Prague<\/strong> Pilsen Region Hradec Kralove Region [\/et_pb_text][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n South Moravian Region Olomouc Region Moravian-Silesian Region [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Organiza\u010dn\u00ed struktura” _builder_version=”4.27.4″ _module_preset=”default” top_divider_color=”#FFFFFF” bottom_divider_color=”#F2F8FF” bottom_divider_flip=”horizontal” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_heading title=”Organisational structure” _builder_version=”4.27.4″ _module_preset=”default” title_level=”h2″ global_colors_info=”{}”][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” min_height=”174px” global_colors_info=”{}”]<\/p>\n CZECRIN | ONCO<\/strong>, as a national network dedicated to supporting clinical research in the field of solid tumour oncology, has a governance structure that ensures transparent and efficient operation. The network operates under the auspices of the national research infrastructure CZECRIN<\/strong>. <\/p>\n All participating institutions and partners have the opportunity to actively participate in shaping the research direction of the CZECRIN | ONCO<\/strong> network and thus contribute to the development of modern cancer care and increasing its availability and quality for patients in the Czech Republic.<\/p>\n [\/et_pb_text][et_pb_heading title=”Leading Investigator” _builder_version=”4.27.4″ _module_preset=”default” title_level=”h3″ global_colors_info=”{}”][\/et_pb_heading][et_pb_team_member name=”doc. MUDr. Radka Lordick Obermannov\u00e1, Ph.D.” position=”Leading Investigator” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/08\/Obermannova.jpg” icon_color=”#f88590″ _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_text_color=”#000000″ header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” text_orientation=”center” custom_margin=”||0px|” custom_padding=”30px|30px|30px|30px|true|true” animation_style=”zoom” animation_intensity_zoom=”8%” border_radii=”on|15px|15px|15px|15px” border_radii_image=”on|40px|40px|40px|40px” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” box_shadow_style_image=”preset1″ icon_hover_color=”#f73145″ global_colors_info=”{}” icon_color__hover=”#f73145″ icon_color__hover_enabled=”on”]<\/p>\n Doc. MUDr. Radka Lordick Obermannov\u00e1, Ph.D. works as a consultant in the field of clinical oncology at the Department of Complex Oncological Care at the Masaryk Cancer Institute in Brno. She specializes in the treatment of patients with tumors of the gastrointestinal tract. She graduated from the Faculty of Medicine of Masaryk University in Brno, where she completed her specialisation training in clinical oncology and postgraduate doctoral studies. Her scientific focus on gastrointestinal cancers has shaped her research career, particularly her interest in optimizing multimodal treatment of esophageal cancer and identifying predictors of treatment response. <\/p>\n Since 2012, she has been the lead physician of the Phase I Unit and is actively involved in the development of new drugs as a principal investigator and co-investigator of Phase I-III clinical trials. Since 2025 she has been the Head of the Clinical Trials Unit at Masaryk Cancer Institute. <\/p>\n Doc. Lordick Obermann is the author of the national recommendations for the treatment of oesophageal and gastric cancer and co-author of the European ESMO recommendations for the treatment of oesophageal cancer. She is an active member of the ESMO Faculty Group on Non-Colorectal Gastrointestinal Cancer and participates in the leadership of the EORTC Gastric Cancer Working Group. She is also a member of the International Gastric Cancer Association (IGCA) and the Czech Cancer Society. <\/p>\n [\/et_pb_team_member][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” custom_padding=”68px|||||” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_heading title=”Discipline Advisory Board” _builder_version=”4.27.4″ _module_preset=”default” title_level=”h3″ global_colors_info=”{}”][\/et_pb_heading][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n The specialty council is a professional platform of the specialty network, which aims to define research priorities in oncology. It focuses on promoting high quality research projects – from identifying topics with high clinical and scientific merit to reviewing proposals for national and international studies.<\/p>\n Members of the specialty board are experienced representatives of the academic and clinical spheres. The implementation of relevant outputs of clinical trials into practice, e.g. by redefining recommended practices, is ensured by close links with the professional society, whose representatives are often also members of the Board.<\/p>\n The Discipline Advisory Board\u00a0thus creates an autonomous professional framework for the strategic direction and development of research activities within the branch network.<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ use_custom_gutter=”on” module_class=”equal-boxes” _builder_version=”4.27.4″ max_width=”1440px” custom_padding=”|||” custom_css_free_form=”.equal-boxes {|| display: flex;||}||||.equal-boxes > .et_pb_column {|| display: flex;||}||||.equal-boxes .et_pb_module {|| height: 100%;||}||” use_custom_width=”on” custom_width_px=”1440px” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”prof. MUDr. Tom\u00e1\u0161 B\u00fcchler, Ph.D. ” position=”Head of the Oncology Clinic” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/11\/Buchler-2.jpg” icon_color=”#f88590″ _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” text_orientation=”center” custom_margin=”||0px|” custom_padding=”30px|30px|30px|30px|true|true” animation_style=”zoom” animation_intensity_zoom=”8%” border_radii=”on|10px|10px|10px|10px” border_radii_image=”on|4px|4px|4px|4px” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_hover_color=”#f73145″ global_colors_info=”{}” icon_color__hover=”#f73145″ icon_color__hover_enabled=”on”]<\/p>\n University Hospital in Motol<\/p>\n [\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”doc. MUDr. Ing. Jakub Cvek, Ph.D.” position=”Head of the Oncology Clinic ” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/11\/Cvek-1.jpg” icon_color=”#f88590″ _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” text_orientation=”center” custom_margin=”||0px|” custom_padding=”30px|30px|30px|30px|true|true” animation_style=”zoom” animation_delay=”100ms” animation_intensity_zoom=”8%” border_radii=”on|10px|10px|10px|10px” border_radii_image=”on|4px|4px|4px|4px” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_hover_color=”#f73145″ locked=”off” global_colors_info=”{}” icon_color__hover=”#f73145″ icon_color__hover_enabled=”on”]<\/p>\n University Hospital Ostrava<\/p>\n [\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”MUDr. Michal Eid” position=”Doctor of the Internal Hematology and Oncology Clinic ” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/11\/Eid-1.jpg” icon_color=”#f88590″ _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” text_orientation=”center” custom_margin=”||0px|” custom_padding=”30px|30px|30px|30px|true|true” animation_style=”zoom” animation_delay=”200ms” animation_intensity_zoom=”8%” border_radii=”on|10px|10px|10px|10px” border_radii_image=”on|4px|4px|4px|4px” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_hover_color=”#f73145″ locked=”off” global_colors_info=”{}” icon_color__hover=”#f73145″ icon_color__hover_enabled=”on”]<\/p>\n University Hospital Brno<\/p>\n [\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”prof. MUDr. Jind\u0159ich F\u00ednek, Ph.D. ” position=”Head of the Oncology and Radiotherapy Clinic” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/11\/Finek-1.jpg” icon_color=”#f88590″ _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” text_orientation=”center” custom_margin=”||0px|” custom_padding=”30px|30px|30px|30px|true|true” animation_style=”zoom” animation_delay=”300ms” animation_intensity_zoom=”8%” border_radii=”on|10px|10px|10px|10px” border_radii_image=”on|4px|4px|4px|4px” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_hover_color=”#f73145″ locked=”off” global_colors_info=”{}” icon_color__hover=”#f73145″ icon_color__hover_enabled=”on”]<\/p>\n University Hospital Pilsen<\/p>\n [\/et_pb_team_member][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ use_custom_gutter=”on” module_class=”equal-boxes” _builder_version=”4.27.4″ max_width=”1440px” custom_padding=”|||” custom_css_free_form=”.equal-boxes {|| display: flex;||}||||.equal-boxes > .et_pb_column {|| display: flex;||}||||.equal-boxes .et_pb_module {|| height: 100%;||}||” use_custom_width=”on” custom_width_px=”1440px” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”MUDr. Jana Katolick\u00e1, Ph.D.” position=”Head of the Oncology and Surgery Department” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/11\/Katolicka-1.jpg” icon_color=”#f88590″ _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” text_orientation=”center” custom_margin=”||0px|” custom_padding=”30px|30px|30px|30px|true|true” animation_style=”zoom” animation_intensity_zoom=”8%” border_radii=”on|10px|10px|10px|10px” border_radii_image=”on|4px|4px|4px|4px” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_hover_color=”#f73145″ global_colors_info=”{}” icon_color__hover=”#f73145″ icon_color__hover_enabled=”on”]<\/p>\n St. Anne’s University Hospital in Brno <\/p>\n [\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”doc. MUDr. Kate\u0159ina Kope\u010dkov\u00e1, Ph.D.” position=”Doctor, Oncology Clinic” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/11\/Kopeckova-1.jpg” icon_color=”#f88590″ _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” text_orientation=”center” custom_margin=”||0px|” custom_padding=”30px|30px|30px|30px|true|true” animation_style=”zoom” animation_delay=”100ms” animation_intensity_zoom=”8%” border_radii=”on|10px|10px|10px|10px” border_radii_image=”on|4px|4px|4px|4px” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_hover_color=”#f73145″ locked=”off” global_colors_info=”{}” icon_color__hover=”#f73145″ icon_color__hover_enabled=”on”]<\/p>\n University Hospital in Motol<\/p>\n [\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”doc. MUDr. Radka Lohynsk\u00e1, Ph.D.” position=”Head of the Oncology Clinic” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/11\/Lohynska.jpg” icon_color=”#f88590″ _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” text_orientation=”center” custom_margin=”||0px|” custom_padding=”30px|30px|30px|30px|true|true” animation_style=”zoom” animation_delay=”200ms” animation_intensity_zoom=”8%” border_radii=”on|10px|10px|10px|10px” border_radii_image=”on|4px|4px|4px|4px” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_hover_color=”#f73145″ locked=”off” global_colors_info=”{}” icon_color__hover=”#f73145″ icon_color__hover_enabled=”on”]<\/p>\n Thomayer University Hospital<\/p>\n [\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_team_member name=”prof. MUDr. Bohuslav Melichar, Ph.D. ” position=”Head of the Oncology Clinic” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/11\/Melichar-1.jpg” icon_color=”#f88590″ _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” text_orientation=”center” custom_margin=”||0px|” custom_padding=”30px|30px|30px|30px|true|true” animation_style=”zoom” animation_delay=”300ms” animation_intensity_zoom=”8%” border_radii=”on|10px|10px|10px|10px” border_radii_image=”on|4px|4px|4px|4px” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_hover_color=”#f73145″ locked=”off” global_colors_info=”{}” icon_color__hover=”#f73145″ icon_color__hover_enabled=”on”]<\/p>\n University Hospital Olomouc<\/p>\n [\/et_pb_team_member][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ use_custom_gutter=”on” module_class=”equal-boxes” _builder_version=”4.27.4″ max_width=”1440px” custom_padding=”|||” custom_css_free_form=”.equal-boxes {|| display: flex;||}||||.equal-boxes > .et_pb_column {|| display: flex;||}||||.equal-boxes .et_pb_module {|| height: 100%;||}||” use_custom_width=”on” custom_width_px=”1440px” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”doc. MUDr. Michal Vo\u010dka, Ph.D.” position=”Head of the Oncology Clinic” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/11\/Vocka-1.jpg” icon_color=”#f88590″ _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” text_orientation=”center” custom_margin=”||0px|” custom_padding=”30px|30px|30px|30px|true|true” animation_style=”zoom” animation_intensity_zoom=”8%” border_radii=”on|10px|10px|10px|10px” border_radii_image=”on|4px|4px|4px|4px” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_hover_color=”#f73145″ global_colors_info=”{}” icon_color__hover=”#f73145″ icon_color__hover_enabled=”on”]<\/p>\n General University Hospital in Prague<\/p>\n [\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”prof. MUDr. Renata Soumarov\u00e1, Ph.D., MBA ” position=”Head of the Oncology Clinic” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/11\/Soumarova-1.jpg” icon_color=”#f88590″ _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” text_orientation=”center” custom_margin=”||0px|” custom_padding=”30px|30px|30px|30px|true|true” animation_style=”zoom” animation_delay=”100ms” animation_intensity_zoom=”8%” border_radii=”on|10px|10px|10px|10px” border_radii_image=”on|4px|4px|4px|4px” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_hover_color=”#f73145″ locked=”off” global_colors_info=”{}” icon_color__hover=”#f73145″ icon_color__hover_enabled=”on”]<\/p>\n Kr\u00e1lovsk\u00e9 Vinohrady University Hospital<\/p>\n [\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”doc. MUDr. Milan Vo\u0161mik, Ph.D.” position=”Head of the Department of Oncology and Radiotherapy” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/11\/Vosmik-1.jpg” icon_color=”#f88590″ _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” text_orientation=”center” custom_margin=”||0px|” custom_padding=”30px|30px|30px|30px|true|true” animation_style=”zoom” animation_delay=”200ms” animation_intensity_zoom=”8%” border_radii=”on|10px|10px|10px|10px” border_radii_image=”on|4px|4px|4px|4px” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_hover_color=”#f73145″ locked=”off” global_colors_info=”{}” icon_color__hover=”#f73145″ icon_color__hover_enabled=”on”]<\/p>\n University Hospital Hradec Kr\u00e1lov\u00e9<\/p>\n [\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”54px|auto||auto||” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_heading title=”Members” _builder_version=”4.27.4″ _module_preset=”default” title_level=”h3″ global_colors_info=”{}”][\/et_pb_heading][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n The members of the CZECRIN | ONCO<\/strong> network represent an active professional community that connects academic and clinical institutions involved in cancer research in the Czech Republic. Unlike the members of the disciplinary council, who are dedicated to the strategic and conceptual direction of research, the members of the network focus primarily on the practical implementation of clinical trials – from protocol design and centre involvement to data collection and sharing of results. <\/p>\n Their activities are crucial for the transfer of scientific knowledge into clinical practice, the development of collaboration between centres and the strengthening of academic research infrastructure in oncology. CZECRIN | ONCO<\/strong> members also act as ambassadors of the network in their institutions and contribute to the development of academic clinical research and the visibility of the Czech oncology community in the international context. <\/p>\n The CZECRIN | ONCO<\/strong> network consists of experts from all over the Czech Republic who are involved in the development of academic clinical research in oncology. [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”|auto|29px|auto||” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_heading title=”Project Management” _builder_version=”4.27.4″ _module_preset=”default” title_level=”h3″ global_colors_info=”{}”][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ module_class=”equal-boxes” _builder_version=”4.27.4″ _module_preset=”default” min_height=”254.6px” custom_margin=”-19px|auto||auto||” custom_css_free_form=”.equal-boxes {|| display: flex;||}||||.equal-boxes > .et_pb_column {|| display: flex;||}||||.equal-boxes .et_pb_module {|| height: 100%;||}||” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_team_member name=”Mgr. Martina Lojov\u00e1, Ph.D. ” position=”Project Manager CZECRIN | ONCO” image_url=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/10\/Lojova_2.jpg” _builder_version=”4.27.4″ _module_preset=”default” header_font_size=”20px” transform_scale=”80%|80%” custom_margin=”||-4px|||” global_colors_info=”{}”]<\/p>\n martina.lojova@mou.cz<\/a> [\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_team_member name=”PharmDr. Kl\u00e1ra Chrom\u00e1 Ku\u010derov\u00e1 ” position=”GENESIS Project Manager” _builder_version=”4.27.4″ _module_preset=”default” header_font_size=”20px” transform_scale=”80%|80%” custom_margin=”||-4px|||” global_colors_info=”{}”]<\/p>\n [\/et_pb_team_member][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|phone” admin_label=”Hiring” _builder_version=”4.27.4″ background_color=”#ffffff” use_background_color_gradient=”on” background_color_gradient_stops=”#ffffff 0%|rgba(41,196,169,0.3) 72%|rgba(42,164,194,0.7) 93%” background_size=”initial” custom_margin=”|||” custom_margin_tablet=”” custom_margin_phone=”” custom_margin_last_edited=”on|phone” custom_padding=”19px|||||” custom_padding_tablet=”|||” custom_padding_phone=”|||” top_divider_style=”asymmetric” top_divider_color=”#FFFFFF” top_divider_height=”226px” top_divider_flip=”vertical” bottom_divider_style=”ramp” bottom_divider_color=”#ffffff” bottom_divider_height=”200px” bottom_divider_flip=”horizontal” saved_tabs=”all” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_heading title=”Collaboration” _builder_version=”4.27.4″ _module_preset=”default” title_level=”h2″ global_colors_info=”{}”][\/et_pb_heading][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n CZECRIN | ONCO <\/strong>creates a space where clinical research, diagnostics and clinical care are linked through the support and development of academic clinical trials in the Czech Republic.<\/p>\n The platform provides a methodological, coordinating and organizational background for collaboration between research teams, clinical sites and diagnostic centres. It supports data sharing, process harmonisation and patient involvement in research activities in line with clinical research principles, including in the field of personalised medicine. <\/p>\n CZECRIN | ONCO<\/strong> thus creates an interconnected infrastructure that strengthens clinical research, enables efficient transfer of knowledge into practice and supports the implementation of innovative approaches in oncology.<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ use_custom_gutter=”on” make_equal=”on” _builder_version=”4.27.4″ width=”89%” custom_padding=”|||” use_custom_width=”on” custom_width_px=”1440px” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_blurb title=”Centre for Precision Oncology ” url=”#top” use_icon=”on” font_icon=”||fa||900″ icon_color=”#6a9ae8″ image_icon_background_color=”rgba(106,154,232,0.3)” image_icon_width=”45px” icon_alignment=”left” _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_text_align=”left” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” image_icon_custom_padding=”25px|25px|25px|25px|false|false” text_orientation=”center” module_alignment=”left” custom_margin=”||0px|” custom_padding=”30px|20px|40px|20px|false|true” custom_padding_tablet=”” custom_padding_phone=”” custom_padding_last_edited=”on|phone” animation_style=”zoom” animation_intensity_zoom=”8%” animation=”off” border_radii=”on|10px|10px|10px|10px” border_width_all=”20px” border_color_all=”#ffffff” border_width_top=”20px” border_color_top=”#ffffff” border_width_right=”20px” border_color_right=”#ffffff” border_width_bottom=”20px” border_color_bottom=”#ffffff” border_width_left=”20px” border_color_left=”#ffffff” border_radii_image=”on|100%|100%|100%|100%” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_font_size=”32px” use_circle=”on” circle_color=”rgba(106,154,232,0.3)” global_colors_info=”{}” image_icon_background_color__sticky_enabled=”#263077″ image_icon_background_color__sticky=”#263077″]<\/p>\n The Centre of Precision Oncology of the Masaryk Cancer Institute (MO\u00da) is a professional and technological base<\/strong> for molecular genetic testing of solid tumours in patients from the Czech Republic.<\/p>\n It has state-of-the-art facilities for molecular diagnostics and bioinformatics and provides:<\/p>\n that form the basis of a personalised approach to the treatment of solid tumours. [\/et_pb_blurb][et_pb_button button_url=”https:\/\/www.mou.cz\/centrum-precizni-onkologie\/t1325″ url_new_window=”on” button_text=”More information” button_alignment=”center” _builder_version=”4.27.4″ custom_button=”on” button_text_size=”14px” button_text_color=”#10275D” button_bg_color=”#ffffff” button_bg_color_gradient_direction=”90deg” button_bg_color_gradient_stops=”#f7828e 0%|#fcb6ab 100%” button_bg_color_gradient_start=”#f7828e” button_bg_color_gradient_end=”#fcb6ab” button_border_width=”0px” button_border_color=”rgba(0,0,0,0)” button_border_radius=”4px” button_letter_spacing=”5px” button_font=”Roboto|700||on|||||” button_use_icon=”off” background_layout=”dark” custom_margin=”-10px|||” custom_padding=”10px|20px|10px|20px|true|true” animation_style=”zoom” animation_intensity_zoom=”8%” box_shadow_style=”preset1″ box_shadow_blur=”30px” box_shadow_color=”rgba(110,130,208,0.14)” button_text_color_hover=”#7a69e6″ button_letter_spacing_hover=”8px” global_colors_info=”{}” button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”on” button_text_color__hover=”#7a69e6″ button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”on” button_letter_spacing__hover=”8px” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_button][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_blurb title=”Project GENESIS Czech Republic” url=”#genesis” use_icon=”on” font_icon=”||fa||900″ icon_color=”#f767b4″ image_icon_background_color=”rgba(247,103,180,0.3)” image_icon_width=”45px” icon_alignment=”left” _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_text_align=”left” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” image_icon_custom_padding=”25px|25px|25px|25px|false|false” text_orientation=”center” module_alignment=”left” custom_margin=”||0px|” custom_padding=”30px|20px|40px|20px|false|true” custom_padding_tablet=”” custom_padding_phone=”” custom_padding_last_edited=”on|phone” animation_style=”zoom” animation_intensity_zoom=”8%” animation=”off” border_radii=”on|10px|10px|10px|10px” border_width_all=”20px” border_color_all=”#ffffff” border_width_top=”20px” border_color_top=”#ffffff” border_width_right=”20px” border_color_right=”#ffffff” border_width_bottom=”20px” border_color_bottom=”#ffffff” border_width_left=”20px” border_color_left=”#ffffff” border_radii_image=”on|100%|100%|100%|100%” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_font_size=”32px” use_circle=”on” circle_color=”rgba(247,103,180,0.3)” global_colors_info=”{}” image_icon_background_color__sticky_enabled=”#263077″ image_icon_background_color__sticky=”#263077″]<\/p>\n The GENESIS project establishes the framework of the Czech National Molecular Tumour Board Platform<\/strong> and the Czech National Precision Medicine Network<\/strong>, which connect diagnostic, research and clinical teams across the country.<\/p>\n GENESIS thus provides a comprehensive source of clinical and molecular data<\/strong> that is useful for both scientific research<\/strong> and practical clinical decision support<\/strong>.<\/p>\n The Centre for Precision Oncology is an expert partner of the GENESIS project<\/strong> and provides its technological, bioinformatics and analytical background. [\/et_pb_blurb][et_pb_button button_url=”#genesis” button_text=”o GENESIS” button_alignment=”center” _builder_version=”4.27.4″ custom_button=”on” button_text_size=”14px” button_text_color=”#10275D” button_bg_color=”#ffffff” button_bg_color_gradient_direction=”90deg” button_bg_color_gradient_stops=”#f7828e 0%|#fcb6ab 100%” button_bg_color_gradient_start=”#f7828e” button_bg_color_gradient_end=”#fcb6ab” button_border_width=”0px” button_border_color=”rgba(0,0,0,0)” button_border_radius=”4px” button_letter_spacing=”5px” button_font=”Roboto|700||on|||||” button_use_icon=”off” custom_margin=”-10px|||” custom_padding=”10px|20px|10px|20px|true|true” animation_style=”zoom” animation_intensity_zoom=”8%” box_shadow_style=”preset1″ box_shadow_blur=”30px” box_shadow_color=”rgba(110,130,208,0.14)” button_text_color_hover=”#7a69e6″ button_letter_spacing_hover=”8px” global_colors_info=”{}” button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”on” button_text_color__hover=”#7a69e6″ button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”on” button_letter_spacing__hover=”8px” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_button][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_blurb title=”Molecular Tumor Board ” url=”#top” use_icon=”on” font_icon=”||fa||900″ icon_color=”#f98d5e” image_icon_background_color=”rgba(249,141,94,0.3)” image_icon_width=”45px” icon_alignment=”left” _builder_version=”4.27.4″ header_font=”Roboto|700|||||||” header_text_align=”left” header_font_size=”18px” header_line_height=”1.7em” body_font=”||||||||” body_line_height=”1.8em” background_color=”#ffffff” image_icon_custom_padding=”25px|25px|25px|25px|false|false” text_orientation=”center” module_alignment=”left” custom_margin=”||0px|” custom_padding=”30px|20px|40px|20px|false|true” custom_padding_tablet=”” custom_padding_phone=”” custom_padding_last_edited=”on|phone” animation_style=”zoom” animation_intensity_zoom=”8%” animation=”off” border_radii=”on|10px|10px|10px|10px” border_width_all=”20px” border_color_all=”#ffffff” border_width_top=”20px” border_color_top=”#ffffff” border_width_right=”20px” border_color_right=”#ffffff” border_width_bottom=”20px” border_color_bottom=”#ffffff” border_width_left=”20px” border_color_left=”#ffffff” border_radii_image=”on|100%|100%|100%|100%” box_shadow_style=”preset1″ box_shadow_blur=”70px” box_shadow_color=”rgba(110,130,208,0.18)” icon_font_size=”32px” use_circle=”on” circle_color=”rgba(249,141,94,0.3)” global_colors_info=”{}” image_icon_background_color__sticky_enabled=”#263077″ image_icon_background_color__sticky=”#263077″]<\/p>\n The Molecular Tumor Board (MTB) is a multidisciplinary expert forum<\/strong> that clinically interprets data from the Precision Oncology Center and the GENESIS project and translates it into treatment decision-making.<\/p>\n It brings together clinical oncologists, pathologists and molecular biologists, geneticists, bioinformaticians, pharmacologists and other experts who:<\/p>\n MTB thus represents a key bridge between laboratory diagnostics and clinical decision-making.<\/strong><\/p>\n [\/et_pb_blurb][et_pb_button button_url=”https:\/\/www.muni.cz\/en\/research\/publications\/1502717″ url_new_window=”on” button_text=”more information” button_alignment=”center” _builder_version=”4.27.4″ custom_button=”on” button_text_size=”14px” button_text_color=”#10275D” button_bg_color=”#ffffff” button_bg_color_gradient_direction=”90deg” button_bg_color_gradient_stops=”#f7828e 0%|#fcb6ab 100%” button_bg_color_gradient_start=”#f7828e” button_bg_color_gradient_end=”#fcb6ab” button_border_width=”0px” button_border_color=”rgba(0,0,0,0)” button_border_radius=”4px” button_letter_spacing=”5px” button_font=”Roboto|700||on|||||” button_use_icon=”off” background_layout=”dark” custom_margin=”-10px|||” custom_padding=”10px|20px|10px|20px|true|true” animation_style=”zoom” animation_intensity_zoom=”8%” box_shadow_style=”preset1″ box_shadow_blur=”30px” box_shadow_color=”rgba(110,130,208,0.14)” button_text_color_hover=”#7a69e6″ button_letter_spacing_hover=”8px” global_colors_info=”{}” button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”on” button_text_color__hover=”#7a69e6″ button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”on” button_letter_spacing__hover=”8px” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” background_enable_image=”off” background_size=”contain” background_position=”center_right” background_horizontal_offset=”4%” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n Before a new medicine reaches patients, it must go through a long and carefully regulated clinical research pathway. CZECRIN connects clinical sites, research teams, and data to ensure that clinical trials are meaningfully designed, conducted to high quality standards, and deliver real benefits for patients \u2014 both in the Czech Republic and across Europe. <\/p>\n Featured in the video:<\/p>\n Regina Demlov\u00e1, Director of the Centre of Excellence CREATIC<\/strong> and CZECRIN<\/p>\n<\/li>\n Jaroslav \u0160t\u011brba<\/strong>, Head of the Department of Paediatric Oncology, University Hospital Brno<\/span><\/p>\n<\/li>\n Radka Lordick Obermannov\u00e1<\/strong>, Head of the Department of Clinical Trials, Masaryk Memorial Cancer Institute<\/p>\n<\/li>\n<\/ul>\n On academic clinical research, the National Institute for Cancer Research (NICR)<\/strong><\/a>, innovative treatment for paediatric patients, and collaboration within ECRIN-ERIC<\/strong>.<\/p>\n [\/et_pb_text][et_pb_video src=”https:\/\/youtu.be\/t7M0p0oZkL8?si=kuYhtBl-tf98OjNq” image_src=”\/\/i.ytimg.com\/vi\/t7M0p0oZkL8\/hqdefault.jpg” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_video][et_pb_button button_url=”https:\/\/czecrin.cz\/en\/behind-every-new-treatment-is-a-clinical-trial-and-behind-many-of-them-is-czecrin\/” url_new_window=”on” button_text=”Read more” button_alignment=”left” _builder_version=”4.27.4″ _module_preset=”5a18c15d-02ca-4e50-a6c0-9677dd27deba” global_colors_info=”{}”][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.27.4″ _module_preset=”default” custom_padding=”12px|||||” top_divider_color=”#d3e5ff” top_divider_style_last_edited=”off|desktop” bottom_divider_style=”asymmetric” bottom_divider_color=”#54a2e3″ global_colors_info=”{}”][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|phone” admin_label=”Klinick\u00e9 studie a v\u00fdzkumn\u00e9 projekty” module_id=”study_onco” _builder_version=”4.27.4″ background_color=”#f2f2fa” use_background_color_gradient=”on” background_color_gradient_stops=”#ffffff 0%|#f2f2fa 50%” background_color_gradient_start=”#ffffff” background_color_gradient_end=”#f2f2fa” background_color_gradient_end_position=”50%” background_size=”initial” z_index=”99″ overflow-x=”visible” overflow-y=”visible” custom_margin=”|||” custom_margin_tablet=”” custom_margin_phone=”” custom_margin_last_edited=”on|phone” custom_padding=”2px|||||” custom_padding_tablet=”|||” custom_padding_phone=”|||” bottom_divider_style=”ramp” bottom_divider_color=”#ffffff” bottom_divider_height=”200px” bottom_divider_flip=”horizontal” saved_tabs=”all” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.4″ custom_padding=”95px|||||” locked=”off” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_heading title=”Clinical trials and research projects” _builder_version=”4.27.4″ _module_preset=”default” title_level=”h2″ global_colors_info=”{}”][\/et_pb_heading][et_pb_text _builder_version=”4.27.4″ text_font=”||||||||” text_font_size=”16px” ul_font=”||||||||” header_font=”||||||||” header_2_font=”Roboto|700|||||||” header_2_font_size=”45px” header_2_line_height=”1.2em” header_3_font=”||||||||” text_orientation=”center” max_width_last_edited=”off|desktop” module_alignment=”center” custom_margin=”|||” custom_padding=”|||” header_2_font_size_tablet=”35px” header_2_font_size_phone=”28px” header_2_font_size_last_edited=”on|phone” global_colors_info=”{}”]<\/p>\n CZECRIN | ONCO<\/strong> collaborates on clinically relevant projects focused on the diagnosis, treatment and prevention of solid tumours, while supporting education and the development of the research environment in its field. Our goal is to ensure that patients with solid tumors have access to personalized and innovative diagnostics, treatment and prevention through well-designed and implemented academic clinical trials. <\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” border_style_all=”none” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_heading title=”Ongoing clinical trials” _builder_version=”4.27.4″ _module_preset=”default” title_level=”h3″ global_colors_info=”{}”][\/et_pb_heading][et_pb_tabs active_tab_background_color=”#2B87DA” active_tab_text_color=”#FFFFFF” module_id=”genesis” _builder_version=”4.27.4″ _module_preset=”default” tab_text_color=”#000000″ tab_letter_spacing=”2px” tab_line_height=”2.7em” custom_margin=”5px|5px|5px|5px|false|false” custom_padding=”5px|10px|5px|10px|false|false” border_radii=”on|10px|10px|10px|10px” border_width_all=”0px” border_color_all=”#2B87DA” box_shadow_style=”preset1″ global_colors_info=”{}”][et_pb_tab title=”GastroPET II” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n Name<\/span><\/strong><\/strong><\/strong><\/p>\n Design<\/span><\/strong><\/p>\n Diagnosis<\/strong><\/span><\/p>\n Description<\/strong><\/span><\/p>\n Contact<\/span> Centres in the Czech Republic<\/strong><\/span><\/p>\n [\/et_pb_tab][et_pb_tab title=”GENESIS” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n Name<\/span><\/strong><\/p>\n Status<\/strong><\/span><\/p>\n Description<\/strong><\/span><\/p>\n Objectives<\/strong><\/span><\/p>\n International cooperation and partnerships<\/strong><\/span><\/p>\n
Head of the Oncology and Surgery Department
St. Anne’s University Hospital in Brno <\/p>\n<\/p>\n<\/p>\n
Doctor of the Internal Hematology and Oncology Clinic
University Hospital Brno<\/p>\n<\/p>\n
Head of the Oncology Clinic
University Hospital Ostrava<\/p>\n<\/p>\n
Head of the Department of Oncology and Radiotherapy
Hradec Kr\u00e1lov\u00e9 University Hospital<\/p>\n<\/p>\n
Head of the Oncology Clinic
Thomayer University Hospital<\/p>\n<\/p>\n<\/p>\n
Head of the Oncology Clinic
University Hospital in Motol<\/p>\n
Doctor, Oncology Clinic
Motol University Hospital<\/p>\n
Head of the Oncology Clinic
General University Hospital in Prague<\/p>\n<\/p>\n<\/p>\n
Head of the Oncology Clinic
University Hospital Olomouc<\/p>\n<\/p>\n
Head of the Oncology Clinic
Kr\u00e1lovsk\u00e9 Vinohrady University Hospital<\/p>\n<\/strong><\/p>\nList of workplaces by region<\/strong><\/h5>\n
FN v Motole<\/a>, <\/span>Fakultn\u00ed Thomayerova nemocnice<\/a>, <\/span>V\u0161eobecn\u00e1 fakultn\u00ed nemocnice v Praze<\/a>, <\/span>FN Kr\u00e1lovsk\u00e9 Vinohrady<\/a><\/p>\n
<\/strong>FN Pilsen<\/a><\/p>\n
<\/strong>FN Hradec Kr\u00e1lov\u00e9<\/a><\/p>\n
<\/strong>FN u sv. Anny v Brn\u011b<\/a>, <\/span>FN Brno<\/a>, <\/span>Masaryk\u016fv onkologick\u00fd \u00fastav<\/a><\/p>\n
<\/strong>FN Olomouc<\/a><\/p>\n
<\/strong>FN Ostrava<\/a><\/p>\n
Their common goal is to link research with clinical practice and to support the implementation of national and international clinical trials.<\/p>\n
543 13 6232<\/strong><\/p>\n
543 13 6239<\/strong><\/p>\n\n
The Centre for Precision Oncology cooperates closely with the University Hospital Brno, both with the Internal Hematology and Oncology Clinic and the Clinic of Paediatric Oncology.<\/p>\n
Together they contribute to the development of data-driven personalised oncology in the Czech Republic<\/strong>.<\/p>\n\n
Every new treatment is built on a clinical trial, and many of these are supported by CZECRIN. <\/h3>\n
\n
\n
\n
\n
\n
<\/strong><\/p>\n\n
\n
\n
National e-platform for molecular tumor boards<\/li>\n<\/ul>\n\n
\n
\n